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Background: The effective management of agitation and other neuropsychiatric and behavioural
symptoms in people with dementia is a major challenge, particularly in care home settings, where dementia
severity is higher and there is limited training and support for care staff. There is evidence for the value
of staff training and the use of psychosocial approaches; however, no intervention currently exists that
combines these elements into an intervention that is fit for purpose and effective in these settings
based on evidence from a randomised controlled trial.
Objective: The objective was to develop and evaluate a complex intervention to improve well-being,
reduce antipsychotic use and improve quality of life in people with dementia in care homes through
person-centred care, management of agitation and non-drug approaches.
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Design: This was a 5-year programme that consisted of six work packages. Work package 1 consisted
of two systematic reviews of personalised psychosocial interventions for behavioural and psychological
symptoms for people with dementia in care homes. Work package 2 consisted of a metasynthesis of
studies examining implementation of psychosocial interventions, in addition to developing a draft
Well-being and Health for people with Dementia (WHELD) programme. Work package 3 consisted
of a factorial study of elements of the draft WHELD programme in 16 care homes. Work package 4
involved optimisation of the WHELD programme based on work package 3 data. Work package 5
involved a multicentre randomised controlled trial in 69 care homes, which evaluated the impact of
the optimised WHELD programme on quality of life, agitation and overall neuropsychiatric symptoms
in people with dementia. Work package 6 focused on dissemination of the programme.
Setting: This programme was carried out in care homes in the UK.
Participants: Participants of this programme were people with dementia living in care homes, and the
health and care professionals providing treatment and care in these settings.
Results: Work package 1: reviews identified randomised controlled trials and qualitative evidence
supporting the use of psychosocial approaches to manage behavioural symptoms, but highlighted a
concerning lack of evidence-based training manuals in current use. Work package 2: the meta-analysis
identified key issues in promoting the use of interventions in care homes. The WHELD programme
was developed through adaptation of published approaches. Work package 3: the factorial trial showed
that antipsychotic review alone significantly reduced antipsychotic use by 50% (odds ratio 0.17, 95%
confidence interval 0.05 to 0.60). Antipsychotic review plus social interaction significantly reduced
mortality (odds ratio 0.36, 95% confidence interval 0.23 to 0.57), but this group showed significantly
worse outcomes in behavioural and psychological symptoms of dementia than the group receiving
neither antipsychotic review nor social interaction (mean difference 7.37 symptoms, 95% confidence
interval 1.53 to 13.22 symptoms). This detrimental impact was reduced when combined with social
interaction (mean difference –0.44 points, 95% confidence interval –4.39 to 3.52 points), but with
no significant benefits for agitation. The exercise intervention significantly improved neuropsychiatric
symptoms (mean difference –3.58 symptoms, 95% confidence interval –7.08 to –0.09 symptoms)
but not depression (mean difference –1.21 points, 95% confidence interval –4.35 to 1.93 points).
Qualitative work with care staff provided additional insights into the acceptability and feasibility of
the intervention. Work package 4: optimisation of the WHELD programme led to a final version that
combined person-centred care training with social interaction and pleasant activities. The intervention
was adapted for delivery through a ‘champion’ model. Work package 5: a large-scale, multicentre
randomised controlled trial in 69 care homes showed significant benefit to quality of life, agitation
and overall neuropsychiatric symptoms, at reduced overall cost compared with treatment as usual.
The intervention conferred a statistically significant improvement in quality of life (Dementia Quality
of Life Scale – Proxy z-score of 2.82, mean difference 2.54, standard error of measurement 0.88, 95%
confidence interval 0.81 to 4.28, Cohen’s d effect size of 0.24; p = 0.0042). There were also statistically
significant benefits in agitation (Cohen-Mansfield Agitation Inventory z-score of 2.68, mean difference
–4.27, standard error of measurement 1.59, 95% confidence interval –7.39 to –1.15, Cohen’s d effect
size of 0.23; p = 0.0076) and overall neuropsychiatric symptoms (Neuropsychiatric Inventory – Nursing
Home version z-score of 3.52, mean difference –4.55, standard error of measurement 1.28, 95%
confidence interval –7.07 to –2.02, Cohen’s d of 0.30; p < 0.001). The WHELD programme contributed
to significantly lower health and social care costs than treatment as usual (cost difference –£4740,
95% confidence interval –£6129 to –£3156). Focus groups were conducted with 47 staff up to
12 months after the end of work package 5, which demonstrated sustained benefits. Work package 6:
the outputs of the programme were translated into general practitioner workshops and a British Medical
Journal e-learning module, an updated national best practice guideline and a portfolio of lay and care
home outreach activities.
Limitations: Residents with dementia were not involved in the qualitative work.
ABSTRACT
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Conclusions: The WHELD programme is effective in improving quality of life and reducing both
agitation and overall neuropsychiatric symptoms in people with dementia in care homes. It provides a
structured training and support intervention for care staff, with lower overall costs for resident care
than treatment as usual.
Future work: It will be important to consider the long-term sustainability of the WHELD programme
and cost-effective means of long-term implementation.
Trial registration: Current Controlled Trials ISRCTN40313497 and ISRCTN62237498.
Funding: This project was funded by the National Institute for Health Research (NIHR) Programme
Grants for Applied Research programme and will be published in full in Programme Grants for Applied
Research; Vol. 8, No. 6. See the NIHR Journals Library website for further project information.
DOI: 10.3310/pgfar08060 Programme Grants for Applied Research 2020 Vol. 8 No. 6
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Ballard et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,




List of tables xv
List of figures xvii
List of abbreviations xix




Dementia in health-care provision and policy 1
Behavioural and psyschological symptoms in dementia 2
The use of antipsychotics in people with dementia 2
Clinical effectiveness of antipsychotic medications 2
Safety concerns for antipsychotics 3
Long-term use of antipsychotics 3
The changing landscape of antipsychotic use 3
Non-pharmacological treatments for behavioural and psychological symptoms of dementia 4
Person-centred care 4
Specific non-pharmacological interventions 5
Rationale for the WHELD programme 5
Aims and objectives 6
Guiding principles for the design of the WHELD programme 7
Work plan 7
Limitations in design 8
Work package 1: systematic reviews of psychosocial and person-centred care
interventions for people with dementia living in care homes 9
Abstract 9
Background 9
Aim and objectives 10
Systematic review of psychosocial interventions to address behavioural and





Implications for delivery of the WHELD programme 13
Systematic review of person-centred interventions and training manuals for care





Implications for delivery of the WHELD programme 15
Concluding remarks from work package 1 15
DOI: 10.3310/pgfar08060 Programme Grants for Applied Research 2020 Vol. 8 No. 6
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Ballard et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
xi
Work package 2: modelling and adaptation of interventions for use within an
NHS context 17
Abstract 17
Background and rationale 17
Aim and objectives 18





Implications for the WHELD programme 20
The WHELD therapy development 21
Rationale 21




Concluding remarks for work package 2 23
Major outputs of work package 2 23
The WHELD programme materials 23
Work package 3: factorial pilot evaluation of non-pharmacological interventions in
combination with person-centred care training in care homes 25
Abstract 25
Background and rationale 25
Aim and objectives 26








Factorial randomised controlled trial 28
Discussion 29
Implications for the WHELD programme 29





Implications for the WHELD programme 30
Concluding remarks for work package 3 30
Success indicator 31
Work package 4: evidence-based and user-driven optimisation of the WHELD
programme for use in a real-world setting 33
Abstract 33
Background and rationale 33
Aim and objectives 34
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xii
Methods 34
Review of use of WHELD programme materials 34
Consultation with expert groups 34
Focus group discussions with care staff 34
Intervention optimisation 35
Results 35
Review of materials in work package 3 35
Consultation with expert groups 35
Focus groups with care staff 36
Refinement of intervention protocol 37
Finalisation of the randomised controlled trial protocol 37
Discussion and implications for the WHELD programme 37
Limitations 37
Concluding remarks for work package 4 37
Major outputs from work package 4 38
Work package 5: randomised controlled trial and field testing of the WHELD
programme in care homes 39
Abstract 39
Background and rationale 39
Aim and objectives 39










Field testing and implementation of the WHELD programme in care homes in the UK 44




Concluding remarks from work package 5 46
Work package 6: dissemination of the study outcomes and impacts 47
Abstract 47
Background and rationale 47
Aim and objectives 47
Additional outreach activities 50
Concluding remarks from work package 6 50
Overall summary and discussion 51
Patient and public involvement in the WHELD programme: discussion and reflections
on the programme by our patient and public involvement co-investigator 51
Contributed by Barbara Woodward-Carlton (lay co-investigator) 51
Investigator team discussion and reflections on the WHELD programme 51
Discussion of implications for practice 53
Recommendations for future research 53
DOI: 10.3310/pgfar08060 Programme Grants for Applied Research 2020 Vol. 8 No. 6
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Ballard et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,




Appendix 1 Working papers in respect of work package 3 73
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xiv
List of tables
TABLE 1 Effect estimates of the WHELD programme in comparison with TAU on key
outcome measures (multiple imputation analysis) 42
TABLE 2 Unadjusted mean costs and mean cost differences at baseline and over
9 months of the study (Great British pounds, 2014–15) 43
TABLE 3 The WHELD programme PPI reporting (reported according to the
GRIPP2 framework) 52
DOI: 10.3310/pgfar08060 Programme Grants for Applied Research 2020 Vol. 8 No. 6
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Ballard et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,




FIGURE 1 Research pathway diagram 8
DOI: 10.3310/pgfar08060 Programme Grants for Applied Research 2020 Vol. 8 No. 6
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Ballard et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,





ANCOVA analysis of covariance
BEHAV-AD Behaviour in Alzheimer’s disease
BPSD behavioural and psychological
symptoms of dementia
CANE Camberwell Assessment of Need
in the Elderly
CASP Critical Appraisal Skills Programme




CSRI Client Service Receipt Inventory
DEMQoL Dementia Quality of Life Scale
ES effect size
FITS Focused Intervention for Training
and Support
GP general practitioner
GRIPP2 Guidance for Reporting
Involvement of Patients and the
Public 2
ICC intracluster correlation coefficient
MRC Medical Research Council
NEST Needs, Environment, Stimulation
and Techniques




NVQ National Vocational Qualification
NWORTH North Wales Organisation for
Randomised Trials
OR odds ratio
PMG Programme Management Group
PPI patient and public involvement
QoL quality of life
QUIS Quality of Interactions Scale
RCT randomised controlled trial
RDAD Reducing Disability in Alzheimer’s
Disease
SD standard deviation
SEM standard error of measurement
TAU treatment as usual
TDG Therapy Development Group
TSC Trial Steering Committee
WHELD Well-being and Health for people
with Dementia
WP work package
DOI: 10.3310/pgfar08060 Programme Grants for Applied Research 2020 Vol. 8 No. 6
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Ballard et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,




This programme addressed antipsychotic drug use and behavioural symptoms in people withdementia living in care homes.
First, we published literature reviews and focus group work that supported non-drug approaches to
improving behavioural and psychological symptoms in people with dementia. Previous studies highlighted
the potential value of personalised activities, social interaction and exercise. A review of available training
manuals showed that there was a concerning lack of evidence for current training packages, with only
4 out of 170 manuals showing benefit for residents with dementia in clinical trials.
We conducted a clinical trial to see whether or not training in person-centred care could be enhanced
through review of antipsychotic prescriptions, promotion of social interaction/personalised activities
or exercise. Combining personalised activities with a review of antipsychotic medication led to both a
50% reduction in antipsychotic use and a significant improvement in some aspects of quality of life for
residents with dementia. There was also a significant reduction in mortality. There were improvements
in symptoms of agitation among people receiving the exercise intervention.
We then developed an optimised version of the Well-being and Health for people with Dementia
(WHELD) programme by combining the effective elements. This was tested in a large randomised
clinical trial, which involved 69 care homes and 847 residents over 9 months. The results demonstrated
benefits in quality of life, a reduction in agitation and improvement in quality of care for residents in
those homes who were receiving the WHELD programme, at a reduced cost compared with usual care.
The findings have been disseminated in numerous publications, a series of general practitioner
outreach activities (workshops and online learning) and an update to national best practice guidelines,
in addition to workshops with care home staff. The WHELD programme has provided important new
information about the best way to provide training and support to empower and enable care home
staff to substantially improve care for people with dementia.
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Neuropsychiatric symptoms, often referred to by consensus as behavioural and psychological symptoms of
dementia, represent a major challenge to the treatment and care of people with dementia. Neuropsychiatric
symptoms affect mortality, quality of life and antipsychotic use. Two major elements of treatment and
care are known to be critical to improving this aspect of service provision. The first is the development
of safe and effective psychosocial interventions for behavioural and psychological symptoms of dementia
as a safe and effective alternative to antipsychotic medication. Since the beginning of this millennium,
there has been a growing focus on a personalised approach to delivering these interventions. The second
element is high-quality training and skills development for staff to enable them to provide the best
possible care, in addition to effective support for clinicians who are working with people in care home
settings. These requirements are highlighted in government directives worldwide. Person-centred care
is recognised as a gold standard in providing care to people with dementia, yet there are no standardised
programmes to support implementation in care homes.
Objectives
The objective of this programme was to improve mental health and reduce the prescription of antipsychotic
drugs for people with dementia in care homes by developing and evaluating an optimised intervention
based on the most effective currently available therapies that can provide a broad range of benefits and
can be routinely implemented as part of NHS care. We also wanted to determine whether or not the
intervention improves quality of life.
This was achieved by addressing the following research questions through six work packages:
l Work package 1 – what is the evidence supporting the use of psychosocial interventions for
behavioural and psychological symptoms of dementia, and the use of staff training programmes
in person-centred care in improving behavioural and psychological symptoms of dementia and
antipsychotic drug use?
l Work package 2 – what factors influence implementation of psychosocial interventions in care
home settings?
l Work package 3 – what is the effectiveness and feasibility of person-centred care training for care
staff alone and in combination with antipsychotic review, social interaction and exercise interventions?
l Work package 4 – what adaptations are required to optimise the effectiveness and implementation
of the Well-being and Health for people with Dementia (WHELD) programme?
l Work package 5 – what is the effectiveness and cost-effectiveness of the optimised
WHELD programme?
l Work package 6 – how can the WHELD programme be effectively disseminated to maximise impact
on care practice and future research?
Methods
Work package 1
In work package 1, the two systematic reviews utilised broad searches of electronic databases including
MEDLINE, PsycINFO, EMBASE, Web of Science™ (Clarivate Analytics, Philadelphia, PA, USA), Clinical
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Trials, British Nursing Index and the Cochrane Library to identify relevant publications that relate to
psychosocial interventions, and a broader search of online search engines to identify existing person-
centred care training manuals. Following protocolised review procedures, quality criteria were applied
to the published studies. A review the efficacy of the training manuals was also considered.
Work package 2
A metasynthesis approach was used to conduct a review of the studies examining the implementation
of psychosocial interventions in care homes. Eligible studies were coded and data were extracted for
thematic analysis. Themes were combined using an interpretive method of metadata synthesis; themes
were grouped where they had greatest explanatory power. Work package 2 also involved a series of
intervention development steps with a therapy development group to create and protocolise an initial
WHELD programme package.
Work package 3
A cluster factorial randomised controlled trial of the WHELD programme was conducted in people
with dementia in 16 care homes. All care homes received person-centred care training and weekly
visits from a research therapist. Eight care homes were randomly assigned to receive antipsychotic
review, social interaction or exercise for 9 months, with most care homes assigned to more than one
intervention. The primary outcome measure was antipsychotic drug use. Secondary outcome measures
were agitation, depression, overall behavioural and psychological symptoms of dementia, quality of
life and mortality. Work package 3 also involved focus group discussions with care home staff from
all of the participating care homes, in which expectations of the study and its implementation were
discussed, and a cost–function analysis conducted with the baseline data from the factorial study.
The analysis utilised data from demographics, medical history, clinical assessment of behavioural and
psychological symptoms of dementia and assessment of unmet needs to define the costs of care and
the associated variables for people with dementia in care homes.
Work package 4
This work package consisted of a series of review and consultation steps that led to the optimisation of
the WHELD programme. This included (1) review of the outcomes of work package 3 with expert and
governance groups, (2) review of the study materials and their usage with the WHELD programme
therapists and (3) focus group discussions with 41 care home staff who were involved in the factorial
trial in work package 3 to understand their experience of involvement in research and the use of the
WHELD programme. The intervention was then refined according to the outputs.
Work package 5
A cluster randomised controlled trial with an embedded cost-effectiveness study was conducted in
people with dementia in 69 care homes, comparing the WHELD programme with treatment as usual.
The primary outcome measure was quality of life (Dementia Quality of Life Scale – Proxy). Secondary
outcome measures included agitation (as measured by the Cohen-Mansfield Agitation Inventory),
behaviour (as measured by the Neuropsychiatric Inventory – Nursing Home version), antipsychotic drug
use and pain (as measured by the Abbey Pain Scale). Staffing inputs and service use data (Client Service
Receipt Inventory) were collected for use in the cost-effectiveness analysis. Focus group discussions
were held with 12 therapists and supervisors to discuss the sustainability of the intervention in care
homes. In addition, a focus group was conducted 9–12 months after the end of work package 5 with
care staff from nine care homes that had received the intervention, to understand factors related to
the sustainability of the intervention beyond the research implementation period.
Work package 6
This dedicated dissemination phase involved a series of tailored activities to maximise the impact of
the WHELD programme. Work included academic publication and presentations, outreach to general
practitioners through regional workshops and the development of a British Medical Journal e-learning
module, updating of national best practice guidelines and additional events for care homes.
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The systematic review of psychosocial interventions identified 40 studies, and highlighted the evidence
supporting the use of reminiscence therapy (effect size 0.33), personalised pleasant activities (effect
size 0.46) and training in person-centred care, with less consistent benefit for personalised music,
exercise and validation therapy. A lack of large-scale randomised controlled trials was identified. The
efficacy and quality review of person-centred care training manuals for staff identified 30 available
manuals, of which only four were supported by randomised controlled trial evidence. Of these four
studies, the studies reported benefit to agitation, depression, overall behavioural and psychological
symptoms of dementia and antipsychotic use. These were the Focused Intervention for Training and
Support; the Needs, Environment, Stimulation and Techniques intervention; Dementia Care Mapping;
and Improving Dementia Care manuals.
Work package 2
The metasynthesis on psychosocial implementation revealed key issues in promoting the use of interventions
in care homes, including the core involvement of staff; buy-in by family members; flexibility to home
structures and working arrangements; ongoing training; supervision and support for care home staff; and
the need for cultural change. These findings were combined with work package 1 to inform intervention
development. The WHELD programme had four key elements: (1) person-centred care training based
on adapted versions of published manuals, (2) antipsychotic review by general practitioners based on
national best practice guidelines, (3) social interaction and (4) exercise. The last two elements were
adapted from published interventions.
Work package 3
In the factorial trial, antipsychotic review significantly reduced antipsychotic drug use by 50% (odds ratio
0.17, 95% confidence interval 0.05 to 0.60). Antipsychotic review plus social interaction significantly
reduced mortality (odds ratio 0.36, 95% confidence interval 0.23 to 0.57) but showed significantly
worse outcomes in behavioural and psychological symptoms of dementia than the group receiving
neither antipsychotic review nor social interaction (mean difference 7.37 symptoms, 95% confidence
interval 1.53 to 13.22 symptoms). This detrimental impact was mitigated by concurrent delivery of social
interaction (mean difference –0.44 points, 95% confidence interval –4.39 to 3.52 points). The exercise
intervention significantly improved neuropsychiatric symptoms (mean difference –3.58 symptoms,
95% confidence interval –7.08 to –0.09 symptoms), but not depression (mean difference –1.21 points,
confidence interval –4.35 to 1.93 points). The focus group discussion findings highlighted that successful
training and support interventions must acknowledge and respond to ‘whole-home’ issues. Three
overarching themes emerged as influential: the need to be attentive in addressing care home staff
expectations and the perceived value of the proposed interventions, the value of sustained relationships
and recognition of good practice.
Work package 4
The review of the WHELD programme and the materials based on therapist records, focus groups with
41 staff from six participating care homes and consultation with the expert and therapy development
group, led to a number of key changes to the intervention. The optimised intervention, therefore,
consisted of the person-centred care and social interaction interventions, with activity elements from
the exercise package and a revised version of the antipsychotic review intervention in which staff
prompted general practitioners for review. The delivery model was adapted for implementation and
cost-effectiveness: the intensive therapist time was replaced with a champions model, in which
nominated care home staff took ownership for interventions in their home. Focus group discussion
outcomes, relating to both the overall research experience and the use of the WHELD programme
materials, reported a generally positive experience for care home staff, although there were issues
with the extra burden of data collection and the time factors in care homes.
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Work package 5
In total, 847 people were randomised to the WHELD programme or treatment as usual, of whom
553 completed the 9-month randomised controlled trial. The intervention conferred a statistically
significant improvement in quality of life (Dementia Quality of Life Scale – Proxy z-score of 2.82,
mean difference 2.54, standard error of measurement 0.88, 95% confidence interval 0.81 to 4.28,
Cohen’s d effect size of 0.24; p = 0.0042). There were also statistically significant benefits in agitation
(Cohen-Mansfield Agitation Inventory z-score of 2.68, mean difference –4.27, standard error of
measurement 1.59, 95% confidence interval –7.39 to –1.15, Cohen’s d effect size of 0.23; p = 0.0076)
and overall neuropsychiatric symptoms (Neuropsychiatric Inventory – Nursing Home version z-score of
3.52, mean difference –4.55, standard error of measurement 1.28, 95% confidence interval –7.07 to
–2.02, Cohen’s d effect size of 0.30; p < 0.001). There was a statistically significant benefit in positive
care interactions measured by the Quality of Interactions Scale (19.7% improvement, standard error of
measurement 8.94%, 95% confidence interval 2.12% to 37.16%, Cohen’s d effect size of 0.55; p = 0.03).
In an additional exploratory analysis, overall benefits were greatest in people with moderately severe
dementia. The WHELD programme significantly reduced health and social care costs compared with
treatment as usual (cost difference –£4740, 95% confidence interval –£6129 to –£3156). Focus group
discussions with 12 of the WHELD programme therapists identified a number of perceptions of the
knowledge and skills required for delivering the intervention. A flexible approach to working with care
homes was a key factor, and therapists reported that supervision and skills development was critical to
their role. They also reported that the champions model, although helpful, required considerable input
to support staff in developing confidence in cascading information to their colleagues. Focus group
discussions with 47 staff from nine participating care homes took place 9–12 months following the end
of the trial and the results were analysed using thematic analysis. A number of sustained benefits and
practices and contributing organisational factors in the care homes were identified.
Work package 6
Dissemination activities were successfully completed in work package 6. Key activities included
regional workshops for general practitioners, which received excellent feedback and response, and the
creation of an e-learning module for general practitioners with the British Medical Journal learning
portal. The national guidelines on behavioural and psychological symptoms of dementia management
were updated and endorsed by NHS England. Additional events and workshops were held with
care home staff, and investigators presented the findings at numerous national and international
conferences. All findings were prepared for publication in peer-reviewed journals.
Conclusions
The WHELD programme successfully optimised a person-centred care training package by augmenting the
intervention with person-centred pleasant activities and antipsychotic review. This gave additional tangible
benefits and made the programme more pragmatic: an essential component for successful implementation.
The definitive randomised controlled trial conducted in work package 5 provides an evidence-based
platform to enable effective implementation in care home settings for people with dementia.
The results of work package 3 suggest the need for some caution when reviewing antipsychotic
medications in people with dementia, and show the importance of providing an evidence-based non-
pharmacological intervention in parallel with antipsychotic discontinuation to maximise the benefit for
people with dementia. Of note, combining antipsychotic review with social intervention did not just
result in the reduction of antipsychotics without worsening of behavioural and psychological symptoms
of dementia, but also led to a significant improvement in quality of life and a significant 30% reduction
in mortality.
The intervention in work package 5 was optimised not just for efficacy, but also to design an intervention
that was more suitable for practical implementation in real-world settings. The intervention conferred
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significant benefits on quality of life, agitation and overall neuropsychiatric symptoms. The standardised
effect sizes (Cohen’s d) for quality of life, agitation and neuropsychiatric symptoms were all between
0.23 and 0.3; these would usually be considered as small effect sizes. For context, the effect size for
treating agitation is more favourable than has been demonstrated in other studies using antipsychotic
medication, and very few studies have demonstrated any impact on quality of life for residents with
dementia. It should also be noted that the intervention targeted all residents with dementia and,
therefore, is difficult to compare it with an intervention delivered to a population with clinically
significant symptoms.
As part of the adaptation of the intervention, there was a less proactive approach to general practitioner
education as part of antipsychotic review and the modified WHELD programme did not achieve an
overall reduction in antipsychotic use in this randomised controlled trial. The general practitioner
intervention has, however, been developed as a British Medical Journal educational module; therefore,
in practice, it should be possible to implement the WHELD programme directly in care homes and
promote the general practitioner educational component in parallel.
Therefore, in summary, the WHELD programme has provided clear evidence to inform clinical and care
practice for people with dementia living in care homes.
First, with regard to antipsychotic drug use, the clinical trials in the programme provide evidence that
advocates the continued judicious prescribing of antipsychotics that follows the changing landscape of
their use in the UK and worldwide. Given the findings related to antipsychotic review, it is critical that
prescribers consider the potential impacts of antipsychotic drug withdrawal and carefully balance the
harm-to-benefit ratio associated with antipsychotic medications.
Second, the programme has clearly demonstrated the value of social interaction and individualised
pleasant activities as part of person-centred care in the treatment and care of people with dementia.
Finally, the qualitative work conducted in this programme has highlighted opportunities and challenges in
implementation of psychosocial approaches in care homes. One that is of particular importance is the
need for ongoing training and support for care home staff to enable and empower them in their role.
Trial registration
This trial is registered as ISRCTN40313497 and ISRCTN62237498.
Funding
This project was funded by the National Institute for Health Research (NIHR) Programme Grants for
Applied Research programme and will be published in full in Programme Grants for Applied Research; Vol. 8,
No. 6. See the NIHR Journals Library website for further project information.
DOI: 10.3310/pgfar08060 Programme Grants for Applied Research 2020 Vol. 8 No. 6
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Ballard et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,





Dementia is characterised by the progressive loss of cogition and function, leading to the loss of
independence and communication ability, and eventually to death. Dementia exerts an enormous
impact on the individuals affected and their families, many of whom provide informal care for long
periods of time. In the context of an ageing population, dementia is also a critical public health issue
with considerable financial implications at a societal level. There are 46 million people with dementia
worldwide, including 850,000 people in the UK, of whom an estimated 250,000 live in care homes.1,2
In the USA, 64% of people receiving Medicare in nursing homes have dementia.3 Care homes provide
full-time residential and nursing care, and represent a unique challenge for health care. There is an
increasing focus in research and policy on the improvement of institutionalised care and the need
for evidence-based interventions for people with dementia that are tailored to this setting.
Dementia in health-care provision and policy
Dementia has a vast impact on health and social care services in the UK. The direct cost of dementia is
£42B per year,1 which is higher than the cost of stroke, heart disease and cancer combined. This was the
basis of the UK’s national dementia strategy for England, developed by the Department of Health and
Social Care in partnership with stakeholder organisations, such as the Alzheimer’s Society (London, UK).4,5
The strategy laid out a unique vision for people with dementia and provided a 5-year plan for building
health and social services for people with dementia that are fit for the 21st century.4
The strategy included two key objectives with particular relevance to care home settings, with strategies
to achieve them. ‘Improving the quality of care for people with dementia in care homes’ (Contains public
sector information licensed under the Open Government Licence v3.0)4 – objective 11 – involved a
government directive to include specialist mental health teams in dementia care within a range of other
measures. ‘The development of an informed and effective workforce for people with dementia’ (Contains
public sector information licensed under the Open Government Licence v3.0)4 – objective 13 – aimed to
provide training and skills for health and social care staff to enable them to deliver the best possible care.
The importance of providing high-quality care for people with dementia who are living in residential
and nursing homes received less attention in the subsequent Prime Minister’s Challenge on Dementia 20205
and the related implementation plan.6 However, the value of an adequately trained workforce and the
provision of evidence-based training was highlighted, and the focus on minimising unnecessary prescribing
of antipsychotic medications to people with dementia was maintained,6 in line with international
recommendations.7 A subsequent report from The King’s Fund, Social Care for Older People: Home Truths,8
has shown the substantial pressures facing the care home sector and the urgent need to use limited
resources more effectively to achieve high-quality care.
People with dementia have complex care needs, particularly those residing in care homes. The majority
of these individuals have moderate or severe dementia and their care needs are influenced by a
combination of cognitive, functional and communication impairments, and medical comorbidities,
and a high frequency of behavioural and psychological symptoms of dementia (BPSD).3,7,9 The NHS
provides for these complex health needs largely through primary care and specialist service consultancy.
Some specialist teams have introduced more proactive liaison services, but these are not widespread.
An effective solution is needed to enable consistent and effective NHS support for people with dementia
and staff, particularly in care home settings where specialist staff are rarely available. Such an NHS
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service would need to improve the general quality of care, the skill base of care staff and the availability
of non-pharmacological interventions and reduce the frequency of potentially harmful antipsychotic
prescribing to improve health and quality of life (QoL) for people with dementia in care homes.
The Well-being and Health for people with Dementia (WHELD) programme grant was run in parallel
with the national dementia strategy for England and the Prime Minister’s challenge on dementia
implementation activities, and within the context of a national drive to improve health-care service
provision and care home services for people with dementia. The programme represents an important
example of the development of a robust evidence-base for dementia care and the improvement of
services in care homes.
Behavioural and psyschological symptoms in dementia
Neuropsychiatric symptoms, often referred to by consensus as BPSD, include aggression, agitation and
restlessness, psychosis, depression, anxiety, elation, disinhibition, sleep disturbance and apathy. BPSD
affect 90% of people with dementia at some point during the course of their condition.10 These BPSD
are critical indicators of QoL and well-being, and have clinically significant effects on the individual and
their caregivers. They present a substantial challenge for health and care professionals, as there are
limited treatment options.10
Current best practice guidelines promote non-pharmacological interventions as the first-line approach
for the treatment of BPSD, and there is a growing evidence base to support the value of this
approach.11 However, there is little guidance on how to implement non-drug treatments and no
structured framework for their widespread use in practice.
The use of antipsychotics in people with dementia
Current best practice guidance limits the use of antipsychotics to short-term prescription (up to 12 weeks)
of risperidone (Risperdal®, Janssen Pharmaceutica, Beerse, Belgium) in intractable cases that are causing
risk to the person or others.
Clinical effectiveness of antipsychotic medications
Systematic reviews have analysed the clinical effectiveness of antipsychotics in people with dementia.
Most studies have focused on the treatment of agitation, aggression, psychosis or overall BPSD.12,13
These analyses are based on 18 placebo-controlled randomised trials, most of which were conducted
over a 10- to 13-week period; however, many of these trials have not been published in full. The best
evidence base exists for risperidone, with five fully published good-quality randomised controlled trials
(RCTs) and a total of 1761 participants.12,13 Adverse events were comprehensively reported in all five
studies.12,13 A meta-analysis reported a significant advantage for risperidone in the treatment of aggression
{–0.84 points on the Behaviour in Alzheimer’s Disease (BEHAV-AD) scale [95% confidence interval (CI)
–1.28 to 0.40 points] at a dose of 1mg and –1.5 points (95% CI –2.05 to –0.95 points) at a dose of 2 mg}.12
This threshold of change indicates a statistically significant difference but only borderline clinically
meaningful benefit at the 2-mg dose of risperidone. Evidence of a clinically meaningful benefit is
restricted to aggression; no clinically meaningful benefit was seen for non-aggressive symptoms of
agitation. Effectiveness is even more limited for the treatment of psychosis with risperidone: statistically
significant benefit but no clinically meaningful benefit was reported in one trial only at 1 mg of
risperidone (BEHAV-AD mean difference –0.14. points, 95% CI –0.25 to –0.03 points).12,13
There are important issues to highlight in the evidence base that relates to antipsychotic drug use in
dementia. First, the evidence for benefit is not equal for all antipsychotic drugs. For example, a meta-
analysis of published trials found no evidence that quetiapine (Seroquel, AstraZeneca, Cambridge, UK)
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confers benefit in the treatment of BPSD.13 A meta-analysis of risperidone studies indicates that there
is statistically significant benefit in risperidone treatment, but with a small effect size [Cohen’s d effect
size (ES) of 0.18 for the treatment of psychosis and 0.2 for treating aggression].12,13 Olanzapine (Zyprexa,
Eli Lilly) and aripiprazole (Abilify, Otsuka) appear to have similar effect sizes, but based on a smaller
number of studies. Other atypical antipsychotic drugs have not been evaluated in RCTs. Second, all
published antipsychotic trials have reported a high placebo response rate (e.g. 45% vs. 55% for risperidone),
indicating that benefit is often related to the general benefits of good clinical practice.
Safety concerns for antipsychotics
The evidence of modest clinical effectiveness of antipsychotics must be balanced against the considerable
risk of adverse events. There are established safety concerns associated with these medications, including
worsening of cognitive decline, cerebrovascular events, sedation, falls and an increased risk of mortality.14
A systematic review15 of 15 RCTs of antipsychotics in people with Alzheimer’s disease (AD) reported a
1% attributable risk of mortality over 12 weeks of treatment (risk difference 0.01, 95% CI 0.004 to 0.02;
p= 0.01). A 12-month double-blind RCT16 examining antipsychotic discontinuation in people with AD, with
a follow-up of participants for up to 5 years, found a significant reduction in mortality associated with
discontinuation (hazard ratio 0.58, 95% CI 0.36 to 0.92), with a risk difference in mortality of 29% after
36 months.16 A subsequent meta-analysis13,17 of all 18 RCTs of atypical antipsychotics for the treatment of
BPSD also found a clinically significant acceleration of cognitive decline in people taking antipsychotics
(Mini Mental State Examination mean difference 0.73 points, 95% CI 0.38 to 1.09 points; p < 0.0001)
over 12 weeks.
Reporting of adverse events is the most complete for risperidone. Full data are not available for
other antipsychotics as a result of the large number of unpublished studies. Of particular concern,
meta-analyses have established a threefold increased risk of cerebrovascular events in people with
AD who take risperidone compared with those taking placebo (odds ratio 3.43, 95% CI 1.60 to 7.32;
z = 3.18; p = 0.001), with a risk difference of 3.1% compared with 1.0% in a pooled analysis.11 Another
important risk is an increased frequency of extrapyramidal symptoms (risk difference by meta-analysis
0.06, 95% CI 0.03 to 0.09, over 12 weeks). Peripheral oedema, sedation, prolonged QTc interval,
infections and abnormal gait have also been identified as potential problems of atypical antipsychotics.13
None of the RCTs of antipsychotic treatment for people with AD reported the impact on well-being or
QoL. However, the relationship between the prescription of antipsychotics and well-being has been
examined in one cohort study18 of 209 people, which suggested that there is lower well-being in people
taking these medications in an analysis controlling for BPSD.18
Long-term use of antipsychotics
Although more limited, evidence on the long-term use of antipsychotic drugs is also beginning to
emerge. Only three trials12,16,19 have evaluated a range of atypical antipsychotic drugs over periods
of 6 months and longer. Adverse events are more marked with longer-term use, with one RCT16
reporting 59% mortality in an intervention group compared with 30% in a placebo group after
36 months. In another 9-month RCT12 of 421 people with AD, 18% of patients receiving risperidone
withdrew from the trial because of adverse events compared with 5% of those patients receiving
placebo. Only one RCT19 has directly evaluated the impact of an antipsychotic (quetiapine) on agitation,
reporting no benefit of the antipsychotic compared with placebo over 6 months. Overall, these studies
have reported no benefit or very modest benefit in the treatment of BPSD over 6–12 months.
The exception is one recent trial20 that compared the effect of withdrawal with the continuation of
haloperidol, which indicated ongoing benefit of continuation in people who had initially responded to
haloperidol treatment. A Cochrane review21 of nine randomised placebo-controlled trials concludes that
long-term prescriptions of antipsychotics can be discontinued without a detrimental effect on BPSD.21
The changing landscape of antipsychotic use
The lack of efficacy and the established safety concerns associated with antipsychotics is the basis of
recommendations that these drugs are not to be used in people with AD. Only risperidone is licensed
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for use in this patient group, for cases of severe BPSD that are causing significant distress or risk to
the individual and where other treatment approaches have failed.7 Despite this, antipsychotic prescribing
has been very common because of the lack of other treatments and the considerable pressure that is
experienced by health professionals to prescribe medication. To address this issue, many governments
and health authorities have promoted initiatives to reduce the unnecessary prescribing of antipsychotics,
including the national dementia strategy for England.7,17,22 These initiatives were supported by evidence
that showed that there were no detrimental effects of withdrawing prescriptions on BPSD.21 As a result,
there has been a marked reduction in antipsychotic use in people with AD and dementia. An audit23
conducted in the UK in 2012 showed a 50% reduction in use of antipsychotics, with 16% of people with
dementia continuing to receive antipsychotics. Similar trends have been documented across Europe and
the USA.24–26 It will now be imperative for authorities to support this success in reducing the unnecessary
prescribing by adapting and updating guidance to reflect the altered landscape of antipsychotic use in
dementia. For example, automatic withdrawal of antipsychotics may not be the best course of action
given that the larger proportion of existing prescriptions may be appropriate for the individuals. Instead,
it will be essential for guidance to focus on continued review of prescriptions and careful monitoring.
The change in policy and pressure to reduce prescriptions also shows the importance of training for
staff in care home settings and the need to enable their access to other effective therapies.
Non-pharmacological treatments for behavioural and psychological
symptoms of dementia
All best practice guidance for the management of BPSD recommend the first-line use of non-
pharmacological approaches unless the symptoms are so severe that they are causing great distress
or risk.11 Although more severe and challenging agitation and aggression often require pharmacological
intervention, this level of BPSD does also respond to intense psychological approaches when tailored
to the individual.
Person-centred care
Person-centred care dictates that all care planning and therapies are embedded within a framework
that is tailored to the needs and wishes of each individual. This personalised approach involves taking
a full history and record of the person’s interests, preferences and abilities, including their hobbies,
culture and religious beliefs, previous employment and their medical and physical status. When
working with people with dementia it is important to involve family members or close friends in
discussions about the person to ensure that a rich life history is created. Person-centred care also
requires a comprehensive medical review to ensure that the care and treatment is appropriate to their
current and ongoing status (see the review by Fazio et al.27 for an excellent overview of person-centred
care). The value of a person-centred care approach is clearly established in the literature;28–31 however,
a systematic review32 has shown a critical issue in how person-centred care is delivered. Of the 170
identified person-centred care training manuals available for use in care settings, only 30 met quality
criteria and of these only four were supported by evidence of effectiveness.32 This disconnect between
available programmes and evidence is concerning and emphasises the importance of a standardised
approach to person-centredness and the use of non-pharmacological approaches. All of the person-
centred training programmes supported by a robust evidence have shown improvement in outcomes
related to BPSD. In one RCT28 of an intensive 9-month training programme, the Focused Intervention
for Training and Support (FITS) programme showed a significant 50% reduction in antipsychotic
prescriptions without worsening of BPSD in 347 care home residents. A trial30 of dementia care
mapping, an in-depth care-planning approach that is based on observation of care followed by
planning to optimise it, reported improvements in agitation (Cohen’s d ES of > 0.5) but no reduction
in antipsychotic use in 298 residents with dementia in 15 care homes. Finally, a cluster RCT33 of an
enriched person-centred care programme that focused on improving QoL for care home residents
with dementia reported significant improvements in mood and numerical benefit in QoL that did not
reach statistical significance in > 200 residents in 10 care homes. The evidence base also supports
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the use of focused interventions using an ‘antecedent, behaviour, consequence’ approach to create
individualised charts for care; these focused interventions are usually delivered by a clinical psychologist.34
A meta-analysis of these studies highlighted significant improvements in agitation and a significant
reduction in antipsychotic use, but no overall significant benefit in mood or QoL.32
Specific non-pharmacological interventions
In addition to person-centred training interventions, which promote a holistic approach to person-centred
care, there are a number of simple approaches available that can be used by health and care professionals
or even family members. These include the Seattle Protocols,35 an approach that focuses on increasing
physical and cognitive activities for people with dementia, such as balance exercises, gardening or walking;
personalised social interaction, an approach that aims to ensure that each individual has dedicated time
when they are interacting with other people through a personalised programme; and simulated presence
therapy, an approach that uses recordings of conversations or events to promote conversation. More
complex approaches include the Needs, Environment, Stimulation and Techniques (NEST) intervention,
which is usually delivered by a recreational therapist, and the brief psychosocial treatment, an approach
that creates a tailored programme of social interaction, which has been used as a lead-in phase in a clinical
trial to effectively reduce placebo response to a drug treatment.29,36
Non-drug approaches to improve well-being are frequently used as part of a person’s care plan.
When non-drug approaches are used within a person-centred care framework these interventions
provide an effective means to control for any unmet need that may lead to BPSD. Some specific
interventions have also been evaluated for their effect on BPSD. Most of these interventions focus on
promoting ‘pleasant activities’, either with or without elements of social interaction. The majority of
trials of these approaches have shown improvements in both agitation and depression;37–41 for example,
reminiscence therapy involves working with an individual to recall life events and memories, often
through the use of props such as photographs or mementoes. Reminiscence therapy may also be
enhanced through the use of audio- or video-recordings of events or family members, as in the
simulated presence therapy described above.42 For this reason, the reminiscence therapy approach
also involves a great deal of social interaction. There is good evidence to support this approach in
addressing symptoms of depression, with six out of seven published studies showing benefit.43 A similar
approach is used in validation therapy, although the evidence base for this is more limited. However,
two small trials have reported beneficial effects on behaviour, including agitation, apathy and sleep
disturbance.44 The effect on other BPSD is less clear. The use of music in the care of people with
dementia has shown some success in a number of trials that report improvements in both agitation
and anxiety, but not depression.43,45,46 A number of studies have also examined the use of physical
exercise, although few have reported significant improvements in BPSD.44
This emerging evidence base suggests that a number of interventions confer some benefit, but no
single intervention has achieved improvement of mental health and reduction of antipsychotic use and
none of the interventions conferred a direct benefit to the QoL of people with dementia in care homes.
Rationale for the WHELD programme
Key NHS priorities include improving mental health and the treatment of mental health problems to
further reduce antipsychotic use and improve the QoL for people with dementia in care home settings.
There is strong evidence that a number of specific person-centred care interventions confer some
benefit, but no single intervention has achieved both an improvement of mental health and a reduction
in psychotropic drug use in people with dementia. Furthermore, none of the interventions evaluated
prior to this programme conferred a direct benefit to the QoL for people with dementia who were
living in care homes. Most importantly, none of these interventions had achieved widespread
implementation in a clinical or care setting as part of routine NHS practice.
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Further research is, therefore, urgently needed to address these key issues. Such research will need
to develop an optimised therapy that combines the most effective elements of the currently available
evidence-based interventions to maximise the breadth of benefit. The intervention needs to be
conceptually integrated, practical to implement in an NHS and care home setting and be cost-effective.
Achieving these objectives will require an integrated programme of research. We tackled this using the
Medical Research Council (MRC)’s framework for complex interventions to model, develop, adapt,
evaluate and disseminate the intervention.
The final stage of the MRC pathway, overcoming the barriers to enable widespread implementation, is
also a major challenge, which cannot be overstated, as this has never been achieved for any therapy
in a care home setting. Research is needed to tailor an optimised therapy to the needs of NHS staff,
care home staff and people with dementia who are living in care homes and their families. In addition,
research is also imperative to understand and overcome the potential obstacles to implementation and
to refine the intervention model through an extensive period of testing in the field. Although much is
known about the effectiveness of interventions, which benefit specific aspects of health and mental
health, any intervention is of limited value unless it is practical and can be implemented routinely in
clinical practice. A comprehensive programme of research is essential to overcome these barriers and to
develop and implement an effective intervention that can be rolled out nationally as an NHS service to
people with dementia in care homes, conferring the benefits to real people in everyday care settings.
This is the basis for the design and delivery of the WHELD programme, which was funded by the National
Institute for Health Research (NIHR) Programme Grants for Applied Research programme in 2012.
Aims and objectives
The overarching aim of the WHELD programme was to improve mental health and reduce the
prescription of antipsychotic drugs for people with dementia living in care homes, by developing and
evaluating an optimised intervention that is based on the most effective currently available therapies
that can provide a broad range of benefits and can be routinely implemented as part of NHS care.
We will also determine whether or not the intervention improves QoL.
To achieve these aims, the specific obectives for the WHELD programme were to:
l update current systematic reviews regarding the most effective interventions to reduce BPSD
experienced by people with dementia in care homes
l optimise the most promising interventions and adapt them for an NHS and care home context
through expert consenus and consultation with health and care professionals
l determine the specific benefits of the interventions in incremental evaluation studies
l develop an optimised intervention that is supported by an operationalised manual, with the specific
aim of maximising the breadth of benefit while remaining practical and cost-effective
l evaluate the optimised intervention and determie the cost-effectiveness in a well-powered,
cluster RCT
l understand the factors that contribute to feasible implementation and sustainability through
consultation with study participants, and to field test the intervention to customise it as a practical
NHS intervention
l proactively disseminate the findings and intervention to enable widespread implementation.
In addition, the WHELD programme aimed to support capacity development within dementia reserach by
providing research training to postdoctoral researchers to enable them to develop careers as independent
researchers, and to build skills and knowledge among NHS care staff through study participation.
SYNOPSIS
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Guiding principles for the design of the WHELD programme
The design and approach taken for the WHELD programme followed a number of guiding principles to
maximise the impact and relevance of the reserach to current practice and evidence. These guiding
principles were as follows:
l Development of interventions – it would have been inefficient and unneccesary to develop new
interventions to promote mental health from basic principles, as effective interventions already
existed at the commencement of the programme. However, these interventions required adaption
for a UK NHS and care home setting and optimisation to improve the breadth of benefit.
l Evaluation of QoL – previous trials had not been able to demonstrate improvement of care home
residents’ QoL. The WHELD programme was, therefore, adequately designed and powered for such
an effect to be demonstrated.
l Meaningful evaluation of interventions – prior to a large RCT, incremental evaluation was
prioritised as a means of determining the effective elements within the overall WHELD programme
intervention, how these elements improve the breadth of benefits and which of these key elements
deliver value for money.
l Importance of field testing – it was deemed essential to undertake an extensive period of field
testing to ensure that the WHELD programme intervention was fully tailored to the needs of the
NHS and the care home sector, and that an intervention was delivered that could be a nationally
implemented cornerstone of NHS treatment for people with dementia who are residing in care
homes. This was particularly important, as it has not previously been possible to achieve widespread
implementation of any intervention in a care home setting.
l Dovetailing with national strategy and ongoing research – the WHELD programme recognises
the need to work within the dynamic climate in UK health-care provision and alongside ongoing
complementary research. The programme was designed to address the priorities published in the
national dementia strategy for England and dovetails with studies examining specialist approaches
for the psychological and pharmacological management of BPSD and other physical and mental
health problems.
Work plan
The WHELD programme followed a pathway through modelling, feasibility, evaluation, dissemination
and implementation, as illustrated in the MRC framework for complex interventions. The programme,
which involved six work packages (WPs), is summarised in Figure 1.
A description of each WP is as follows:
l WP1 – update and publish a systematic review to show the service models and interventions for
people with dementia living in care homes with the best available evidence base.
l WP2 – model and adapt exisiting effective interventions to a UK NHS context.
l WP3 – evaluate the breadth of benefits in an incremental design to establish the most effective and
cost-effective combination of intervention elements (factorial study).
l WP4 – develop an optimised intervention (WHELD), ‘welding together’ the most effective elements
of the best available interventions, and develop a standardised manual and training programme for
care staff.
l WP5 – evaluate the full breadth of benefit conferred by the intervention through a large cluster
RCT with parallel cost-effectiveness and process evaluations.
l WP6 – disseminate the findings and the WHELD programme to enable widespread
national implementation.
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Limitations in design
In designing the study, we were mindful of the challenges of measuring QoL in people with moderate
to severe dementia and, therefore, relied predominantly on a proxy measure. Within any RCT of a
non-pharmacological intervention, it is a difficult decision whether to opt for treatment as usual or
for an active control in the comparision arm. We used an active control (person-centred care) in WP3,
which involved 16 care homes, but opted for a treatment as usual control in WP5, as a result of the
scale of the study in 69 care homes. This may have inflated the magnitude of observed benefits with
the WHELD programme in WP5.
The training and supervision in the intervention was delivered directly to care staff, who participated in
qualitative work. However, we recognise that residents with dementia who received the intervention
that was delivered by the staff were not included in the qualitative studies and could provide a
valuable perspective.












• RCT to determine effective elements of the WHELD programme
• Focus groups with participating care staff prior to RCT
• Optimisation of WHELD programme based on WP3 results
• Care staff focus group on feasibility
• Therapy development group
• Large randomised clinical trial with health economic assessment
• Focus group with WHELD therapists
• Focus groups with care staff following RCT completion
    regarding sustainability
• Dissemination
• Qualitative metasynthesis
• Optimise interventions and adapt
    for NHS context
• Systematic reviews
FIGURE 1 Research pathway diagram.
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Work package 1: systematic reviews of
psychosocial and person-centred care
interventions for people with dementia
living in care homes
Abstract
Objectives: WP1 sought to ask two specific research questions: (1) what is the evidence supporting
the use of psychosocial interventions for BPSD? and (2) what is the quality and efficacy of existing
psychosocial interventions and staff training programmes in person-centred care in improving BPSD
and antipsychotic use?
Methods: Two systematic reviews were conducted. One examined publications relating to psychosocial
interventions and the other conducted a search to identify person-centred care training manuals.
Quality criteria were applied and the efficacy of manuals was considered.
Results: The systematic review of psychosocial interventions identified 40 studies and highlighted the
evidence supporting the use of reminiscence therapy (ES 0.33), personalised pleasant activities (ES 0.46)
and training in person-centred care. The modest number of adequately powered RCTs was highlighted.
The efficacy and quality review identified 30 manuals meeting the quality criteria, of which only four
were supported by RCT evidence. The studies reported benefit to agitation, depression, overall BPSD
and antipsychotic use.
Conclusions: The reviews showed the limitations of the evidence base related to person-centred care
training, but the combined reviews indicate that there are some benefits in the use of psychosocial
interventions for people with dementia living in care homes.
Background
Behavioural and psychological symptoms of dementia represent a major challenge to dementia care
and are associated with important clinical outcomes.14,47 There is a high level of unmet need,
particularly for individuals living in care homes.2
A major element of dementia care is the development of safe, effective psychosocial interventions that
improve residents’ care, reduce behavioural and psychological symptoms in people with dementia and
offer an alternative to antipsychotic medication. There is a growing focus on a personalised approach
to these interventions. Another element of dementia care is the need for high-quality training, in
addition to effective support for clinicians. These requirements are highlighted in government
directives worldwide.7,17,48
As the starting point for the WHELD programme, WP1 aimed to synthesise the landscape of
non-pharmacological treatment approaches and the resources that are currently available. This work
directly informed decisions regarding the design and delivery of the WHELD programme.
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Aim and objectives
The aim was to address and update gaps in the evidence base to inform the development of the
WHELD programme.
The two major objectives were to:
1. update a systematic review highlighting service models and interventions for people with dementia
living in care homes
2. conduct a two-pronged systematic review of quality and efficacy of existing person-centred care
interventions, with a focus on the impact on BPSD and antipsychotic use.
Systematic review of psychosocial interventions to address behavioural
and psychological symptoms experienced by people with dementia living
in care homes
Rationale
The relevant literature includes a substantial number of studies investigating treatment approaches
for BPSD. However, the majority of these studies focus on pharmacological intervention and of those
evaluating psychosocial approaches only a fraction use robust, good-quality methodology to investigate
effectiveness.49–52 Of the recent systematic reviews, only O’Neil et al.53 focused on the treatment of
individual BPSD and none focused on the benefits of personalised psychosocial interventions. Despite
the high profile of antipsychotic use as an issue in clinical practice, to our knowledge, no systematic
reviews have considered this outcome.28 A considerable number of new studies have been published
since the most recent systematic reviews, which include studies published before 2009.53
Methods
The work followed a systematic review protocol43 and focused on studies published from 1 January
2012 to 31 December 2012.
Development of review criteria
A preliminary search was undertaken to identify studies that examined the impact of psychosocial
interventions on BPSD and antipsychotic use in people with dementia living in care homes. The search
was subsequently refined by a specialist panel to focus on personalised psychosocial interventions.
Selection of included studies
A qualified librarian and one investigator performed the initial search. Two investigators examined
these results and excluded irrelevant articles. Personalised psychosocial interventions were grouped
into six categories of interventions.
Quality of included studies
A traffic-light system was used to describe a risk-of-bias analysis, using an adaptation of the 2008 Cochrane
review framework (as reported in 2012 by Corbett et al.54). The six criteria (adequate sequence selection,
allocation concealment, blinding, incomplete outcome data, freedom from selective reporting and freedom
from other bias) were each rated as green, amber or red to produce an overall rating.
Data analysis
Quality assessment used operationalised Cochrane criteria54 and the Preferred Reporting Items for
Systematic Reviews and Meta-analyses (PRISMA) guidance. A descriptive summary was developed for
the impact of each type of intervention. Where available, the ES was included.
WORK PACKAGE 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
10
Results
Studies included in the review
In total, 641 studies were identified in the initial search, of which 597 were excluded. A total of
40 studies were included, of which nine were rated green, eight were rated amber and 23 were
rated red. None of the included studies contained a health economic analysis.
Description of studies
The 40 studies comprised 26 RCTs and 14 studies with quasi-experimental designs. The studies were
performed in 13 different countries, using 66 different outcome measures. A total of 20 (50%) were
published in the last 4 years. The studies were distributed into the six categories: reminiscence (n = 6),
personalised music (n = 7), personalised pleasant activities with or without social interaction (n = 10),
validation therapy (n = 2), personalised exercise/physical activities (n = 12) and person-centred care
training and practice development (n = 3).
Reminiscence
Six studies55–60 evaluated reminiscence. Two studies had a parallel-group RCT design.55,58 There was
substantial variability in sample size (range 30–115 participants, median 67 participants), duration
(range 3–8 weeks, median 7 weeks), frequency of intervention and session length (30–60 minutes).
Results consistently showed significant benefit to depression (ES 0.33).56–59 Other outcomes were less
consistently evaluated and benefit was variable. One of two studies examining BPSD reported
benefit.60 None evaluated agitation.
Personalised music
Personalised music was examined in seven studies,45,46,61–65 including four parallel-group RCTs.45,46,61,65
The studies included 20–104 participants (median 55.5 participants) and lasted 4–42 weeks (median
6 weeks), with variable frequency and session length (30–50 minutes). Benefit was identified in three
studies that examined agitation,45,46,64 including two RCTs.46,64 There was no difference in treatment
‘dose’. The ES of personalised music on agitation ranged from 0.43 (in favour of the control) to
0.66 (median 0.21). There was some evidence of benefit to overall BPSD46 and anxiety,45 but not
depression.46 Subsequent work has suggested that there is a possible impact on depression.66
Personalised activities
Ten studies were included,37–39,41,67–72 of which seven were RCTs. The studies had 37–231 participants
(median 147.5 participants) and lasted 1–36 weeks (median 4 weeks), with variable frequency and
session length (30–240 minutes). Four studies37–39,67 reported benefit to agitation (ES 0.24–0.91, median
0.46). One study41 reported benefit to depression and four studies37,38,69,71 reported benefit to mood.
Validation therapy
Two studies44,73 analysed validation therapy. One 12-week trial of 30 patients (session length 45–60
minutes) showed benefit to BPSD in combination with reminiscence therapy.73 Another 16-week trial
of 50 patients also saw benefit to agitation, apathy, irritability and night-time behaviour.44
Personalised exercise
In total, 12 trials of exercise interventions were identified,74–85 including 11 RCTs. Only four74,76,78,82 met
criteria for personalised approaches; these involved 56–682 participants (median 205 participants)
over 5 weeks (median 15 weeks), varied in frequency and session length (30–60 minutes) and showed
limited benefit.
Person-centred care training and practice development
Three cluster RCTs focused on person-centred care training,28,30,33 which included 289–349 participants
(median 293 participants) and lasted 4–18 months. Two evaluated the impact on antipsychotic use,
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with one indicating a significant reduction in use.28 One study30 reported benefit to agitation.
All examined mood, but only one33 reported significant benefit.
Further evaluations were undertaken for interventions that showed significant benefit to explore
factors associated with favourable treatment response, defined as at least four studies examining
the same outcome, with > 50% of studies indicating benefit. Reminiscence had a beneficial impact on
mood in all studies, indicating a broad spectrum of benefit; however, further work is needed to clarify
whether or not reminiscence benefits people living at home, younger individuals and those with severe
dementia. Studies of personalised pleasant activities, with or without social interaction, indicated
significant benefit for people with moderate to severe dementia who were living in nursing homes.
Further work is needed to clarify whether or not there are benefits in other settings, in people with
severe dementia or in younger individuals.
Discussion
This WP successfully completed and published a systematic review of the evidence supporting the use
of psychosocial interventions for BPSD in care home settings.43
This review has progressed the understanding of the potential differential benefits of interventions
on specific BPSD, in particular through reminiscence on mood and depression (ES 0.33)55–57 and
personalised pleasant activities on agitation (ES 0.46).37–39,67 This provides valuable new evidence
on the best use of psychosocial interventions for BPSD.
Only three RCTs28,30,33 were identified that evaluated person-centred care training interventions.
Although all three RCTs reported benefit in at least one key outcome, benefits were inconsistent.
One RCT reported reduced antipsychotic use,28 one improved agitation30 and one improved mood.33
Further work is needed to optimise these interventions. Evidence regarding personalised music was
inconsistent and mainly focused on the treatment of agitation, although interpretation was challenging
and further work is needed. Despite the larger evidence base for exercise, only four studies43 focused
on personalised approaches to exercise and the impact on BPSD and showed that there was limited
benefit. Importantly, there is no evidence that any of the interventions specifically conferred benefit
to psychosis.
Limitations
The outcome measures and trial duration in the included studies varied considerably, precluding a
meta-analysis. In addition, we did not examine health economic outcomes. Only one study43 examined
continued benefit beyond the period of the intervention, which is a key consideration for the
development of the WHELD protocol.
It should also be noted that the study limited the period of inclusion to studies published after 2000,
to focus on more recent and relevant studies. However, pre-2000 studies were consistent with our
conclusions; for example, benefits were reported for social interaction,86 personalised pleasant
activities without social interaction,86 personalised physical activity,87 an educational programme88
and reminiscence.89
An additional limitation is the variety in theoretical frameworks underpinning the interventions and
their frequency, session length and duration. Despite this, the review presents clear information to
inform clinical practice and the next phases of the programme. This work is valuable in improving the
targeting of individual BPSD with specific personalised psychosocial interventions, and in driving key
research questions.
WORK PACKAGE 1
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Implications for delivery of the WHELD programme
This review demonstrated valuable differential effects between different personalised psychosocial
interventions that could have implications for the tailoring of care packages according to symptoms.
It showed the importance of person-centred care interventions, pleasant activities for the treatment of
agitation and the use of reminiscence therapy for mood. These findings were pulled through to WP2
and directly informed the development of the WHELD programme.
In addition, the review indicated areas of need for the design of the WHELD programme and protocol,
including the need to focus on health economics, to improve the understanding of the impact of
duration and frequency of specific interventions on ES and to develop a more detailed understanding
of the impact of the conceptual frameworks on the outcome, and whether or not this can be used to
optimise interventions. The review also emphasised the importance of understanding the level of care
staff education that is needed to deliver specific interventions effectively, as well as the effect of the
care environment and leadership on implementation.
The review was conducted based on a literature search up to December 2012, as part of the WHELD
programme and to inform therapy development. A rapid updating search in October 2019 and citation
tracking from out-published papers did not identify any relevant new studies that would change our
conclusions.
Systematic review of person-centred interventions and training manuals for
care home staff working with people with dementia
Rationale
Global government initiatives emphasise the importance of training for care staff and the need to improve
access to effective psychosocial therapies for people with dementia.5–7,48 These recommendations have
resulted in a proliferation of training programmes that are promoted to care providers; however, the
evidence to support the effectiveness of these programmes is unclear.
In the UK, increasing the skills of the workforce through training would cost an estimated £546M.
Therefore, it is vital to have a clear understanding of the available training courses and their evidence
base to support clinical and care interventions.
In line with the overall WHELD objectives, we focused on the implications for BPSD and antipsychotic
use for this element of WP1.
Methods
See the published output for the full methodology.32
The review had two objectives:
1. quality review – to review the quality of the available training manuals for person-centred care of
people with dementia
2. efficacy review – to undertake a systematic review of RCTs that deliver training interventions to
improve person-centred care.
Quality review
Manuals and training packages were identified through electronic searches, screened for eligibility and
scored for comprehensiveness and degree of operationalisation. Studies scoring ≥ 3 for both criteria
were deemed to provide broad person-centred interventions to address BPSD and/or antipsychotic use
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and were suitable for implementation. All papers and manuals that were published up to 30 June 2012
were included.
Data were extracted and manuals were separated into categories according to the type of intervention or
training. They were rated independently by three investigators. The type of research evidence available was
noted and summarised as anecdotal, qualitative study, open trials, quasi-experimental or RCTs.
Efficacy review
All RCTs and quasi-experimental studies that had a control group that addressed BPSD and/or
antipsychotic use were included in the efficacy review. The methodological quality of studies was
assessed applying the Cochrane system.54
Data that pertained to BPSD or antipsychotic prescribing were extracted for meta-analysis. The
meta-analysis was undertaken with the Comprehensive Meta-analysis package (version 2, Hewlett
Packard, Palo Alto, CA, USA) for key outcomes (agitation, depression and total neuropsychiatric
inventory) reporting standardised mean differences with 95% CIs and for antipsychotic drugs when
data were available from two or more studies.
Results
Quality review
In total, 170 packages were identified. In total, 63 met the screening criteria and 30 were shortlisted,
having obtained sufficient criteria scores. Of these, four were supported by RCT evidence.
Efficacy review
Seven studies were identified,28,30,37,90–93 of which five were parallel-group RCTs. Three studies28,30,93
evaluated the impact of person-centred care training on antipsychotic use, with two studies indicating
significant reductions of 12.8%93 and 21.5%,28 which was confirmed by a meta-analysis (standard
difference in means 1.08, z= 2.97; p= 0.003). Quantitative evaluation of agitation was available for four
studies,28,30,37,92 with an overall significant benefit. Benefit to depression was reported in assisted living
environments, but not in care home settings. One trial reported global impact on BPSD and showed a
significant 8.7-point improvement. All six studies received a ‘green’ score for quality and risk of bias using
the Cochrane quality review process.54
Excluded studies
Several other interventions did not meet the inclusion criteria, including Reducing Disability in
Alzheimer’s Disease (RDAD)31 and cognitive stimulation therapy.94 Reasons for exclusion included
focusing on specific domains, not focusing on BPSD or antipsychotic use, being in non-care home
settings or interventions delivered directly to people.
Outcome of combined quality and efficacy review
Only four manuals met the quality criteria and had published clinical trial evidence of efficacy:
l Focused Intervention of Training for Staff28,95 – a 10-month person-centred care training package
that was delivered by a mental health professional, conferring a 19.1% reduction in antipsychotic
use (95% CI 0.5% to 37.7%).
l A collection of evidence-based protocols for non-drug strategies – NEST29,91 and the manual ‘Simple
Pleasures’,90 conferring improvements in agitation [Cohen-Mansfield Agitation Inventory (CMAI);
p = 0.01] and depression (Geriatric Depression Scale; p = 0.001).91
l Dementia Care Mapping – a detailed observational and care planning approach for care homes that
showed a significant reduction in agitation (CMAI; p = 0.01) and falls (p = 0.02).30
l Improving Dementia Care96 – a practical training and staff development resource that showed a
reduction in agitation, although the outcomes varied between sites (CMAI; p = 0.01).30
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Discussion
This review identified evidence that demonstrated the benefits of person-centred care interventions on
agitation and antipsychotic use in people with dementia living in care homes. However, this was based
on intervention studies that were performed on only a fraction of the training programmes that are
currently available. Only 30 (18%) of the manuals followed good educational and person-centred care
principles and only four (2.3%) had clinical trial evidence. Thus, over 80% of the available training
packages are of variable quality and 98% are not evidence based; this is extremely concerning. Health
care and care home sectors are investing in training following government directives, largely in
programmes that carry no evidence of benefit. There is a need for person-centred care intervention
training to be evidence based if it is to provide better social and medical care. Of note, interventions
for which there is evidence of benefit were delivered over a period of at least 4 months, and involved
ongoing clinical supervision or support to embed implementation into care home practice. This suggests
that one-off training packages or classroom-based training would probably be ineffective.
The literature does not currently provide any evidence for effectiveness on psychosis, depression and
QoL. This is an important priority for further research, as highlighted by the Department of Health and
Social Care.97
Limitations
Although the review incorporated national and international manuals, the review was limited to
the English language. The search for published manuals was complemented by a search for RCTs,
focusing on training and activity-based trials, thereby mitigating the limitations and ensuring a broad
international perspective. In addition, training programmes without available manuals were excluded.
Several manuals had a broader framework for care delivery rather than a specific focus on BPSD. It is,
therefore, likely that wider benefits were not captured.
Implications for delivery of the WHELD programme
This review showed the major disconnect between the interventions that are routinely available and
commissioned and the evidence base. This added further weight to the overall rationale of the WHELD
programme.
The review provided key indicators of elements that are required for a successful person-centred
intervention, including the importance of consistent, long-term support for staff. It indicated the need to
evaluate effectiveness on psychosis, depression and QoL, in addition to agitation and antipsychotic use.
The limited number of available training manuals without direct clinical trial evidence of benefit for people
with dementia is alarming, and emphasises the importance of a feasible, effective training programme.
Concluding remarks from work package 1
Work package 1 successfully delivered the objective of updating the current evidence base with systematic
reviews. It highlighted pleasant activities and social intervention as priority areas for addressing agitation,
and reinforced our view that augmentation of existing interventions is needed to deliver comprehensive
benefit and improve QoL.
Finally, WP1 identified an alarming number of available training manuals that are not evidence based,
and strongly emphasised the need for an evidence-based manual. These findings were taken forward
by the Therapy Development Group (TDG) in WP2.
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Work package 2: modelling and
adaptation of interventions for use
within an NHS context
Abstract
Objectives: WP2 sought to identify the factors that influence implementation of psychosocial
interventions in care home settings and to develop the WHELD programme for evaluation, based on
the outputs and findings from WP1.
Methods: A metasynthesis approach was used to conduct a review of studies that examine the
implementation of psychosocial interventions in care homes. Data were analysed by thematic analysis
using an interpretive method of metadata synthesis, grouping themes where they had the greatest
explanatory power. These findings and WP1 results were used by a TDG to create and protocolise a
WHELD programme package.
Results: The meta-analysis revealed key issues in promoting the use of interventions in care homes,
including the core involvement of staff, buy-in by family members, flexibility of care home working
arrangements, training, supervision and support for staff and the need for cultural change. These
findings, combined with WP1, informed development of the intervention. The WHELD programme
involved four key elements: person-centred care training that was based on adapted versions of
published manuals, antipsychotic review by general practitioners (GPs) that was based on national
best practice guidelines, social interaction and exercise, both of which were adapted from published
interventions.
Conclusions: The work completed in WP2 follows a clear pathway, from theoretical basis to conceptual
framework to a tangible operational intervention. The WHELD programme represents a synthesis of
knowledge that was drawn from clinical trial data, existing resources and qualitative analysis, and was
collated for use by a broad expert consensus process.
Background and rationale
Work package 1 illustrated the strength of evidence for several psychosocial interventions and
manualised person-centred care programmes that confer benefit on mental health and antipsychotic
medication use for people with dementia living in care homes. Promising interventions were identified,
including staff training, person-centred care and structured social interaction approaches and exercise.
Importantly, none of the interventions directly improved QoL for care home residents or achieved
widespread implementation as part of routine care practice. WP1 also showed the lack of evidence-based
training programmes and the importance of an integrated approach to ongoing support for care staff.
The work carried out in WP1 pointed towards the need for a whole-systems approach to improve
person-centredness in care homes with integration of the most effective individual interventions, and
to develop an understanding of the factors that influence implementation.
Therefore, WP2 encompassed a further review to gather qualitative data on aspects of psychosocial
intervention design, followed by a series of therapy development steps to adapt and combine the key
components of established effective interventions.
DOI: 10.3310/pgfar08060 Programme Grants for Applied Research 2020 Vol. 8 No. 6
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Ballard et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
17
Aim and objectives
The overall aim of WP2 was to create a conceptually integrated evidence-based intervention that was
practical to implement in UK care home settings.
The objectives of WP2 were to conduct a:
1. systematic review and metasynthesis of qualitative research to identify factors that influence the
implementation of psychosocial interventions.
2. series of expert panel and TDG sessions to develop a person-centred care intervention by combining
the best elements of existing interventions in a way that is both conceptually integrated and practical.
Implementation of psychosocial interventions: systematic review
and meta-analysis
Rationale
Qualitative methods are the most appropriate approach for addressing complex questions regarding
the implementation and acceptability of psychosocial interventions in care homes. Individual studies
provide insight into how different psychosocial interventions are used and experienced within residential
settings. Integrating these findings in a qualitative metasynthesis promises to enhance their implementation
and impact on health policy and clinical practice.98,99 WP2 used this approach to help to understand
and overcome the potential obstacles to implementing psychosocial interventions as part of routine
practice. To our knowledge, this is the first systematic review and metasynthesis of the qualitative
evidence in this field.
Methods
Full details of the methodology are provided in a published output.100 Systematic review methodology
was used to identify relevant research regarding the use and effectiveness of psychosocial interventions
that were designed to improve outcomes for people with dementia in care homes, from the perspective
of people with dementia, relatives or care staff.101 Papers published between 1 January 1995 and
31 January 2011 were included in the review.
Two investigators independently assessed relevant papers for methodological quality using the Critical
Appraisal Skills Programme (CASP) checklist.102 We opted for an inclusive strategy103 and, in common
with another synthesis,99 the quality appraisal process was used as a criterion to judge the value of
papers with respect to their contribution to the synthesis. Themes were included in the meta-synthesis
if they were supported by data from at least one article that was judged as being of reasonable quality.
A description of the main concepts derived from each paper was recorded,104 and shared constructs
across studies and areas of discordance were noted. The themes were combined using an interpretive
method of metadata synthesis by grouping themes where they had the greatest explanatory power.
A taxonomy was constructed that categorised findings in three domains, which are discussed below.
Results
The review identified 39 papers (34 studies),105–143 of which 29 were rated as being of reasonable
quality or better (CASP ≥ 7), with a good level of agreement between reviewers (weighted Cohen’s
kappa = 0.66). The 10 papers that did not meet the quality criteria were primarily rated as weak,
owing to a lack of rigour in data analysis or a failure to comment on the bias in the study
design.108,116,117,120,123,124,126,128,133,134
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The 34 studies spanned a broad range of psychosocial intervention types, which included exercise and
other therapeutic activities (n = 6),110–112,117,125,138 music (n = 5),129–132,136 reminiscence (n = 4),113,121,128,135
communication strategies (n = 3),106,108,141 models of dementia care (n = 3),114,133,143 methods of
orientation (n = 2),109,124 animal interventions (n = 2),122,123 staff training and supervision (n = 3),118,127,140
and other (n = 6).105,115,119,137,139,142 Common themes were identified in three overarching categories:
elements of a successful intervention, conditions required for a successful intervention and challenges
to a successful intervention.
Elements of a successful intervention
Aspects that predicted successful interventions were categorised by whether they elicited benefit to
people with dementia or to care staff.
People with dementia
Beneficial interventions often supported people with dementia in ‘connecting with others’ by enhancing
communication. Conversation was stimulated between residents, staff and family through various
means, including animals, dolls, music, reminiscence items or ‘memory boxes’.107,116,122–124,128,136,139 Studies
reported particular success with volunteer-led approaches.122,123,137 Music and dance interventions
were useful in supporting people to better express emotions,107,111,112 with group activities improving
co-operation and a sense of inclusion.125,131,139,143
Successful interventions also focused on ensuring that participants felt that they were making a
meaningful contribution to an activity, for example through taking care of an animal.107,113,122,128,135,137,139,143
Structured or spontaneous reminiscence was also a valuable element.112,116,122,123,132,135,139
Care staff
There was a consensus that care staff find psychosocial approaches valuable in enabling them to build
better relationships with individuals and their families.113,115,118,119,128 Closeness between staff and residents
was fostered by experiential learning, which encouraged staff to consider the perspectives of a person with
dementia114,118,143 and gave them the opportunity to reflect on their approach to residents and the likely
impact on them. Reflection reportedly led to changes in care-giving behaviour,118,127,128 particularly when
supervision from senior staff was available.113,127,140
Conditions required for a successful intervention
All of the studies illustrated the reliance on staff to support people with dementia to access the
psychosocial interventions.107,125,126,134 Person-centredness and the importance of relationship
building was a major theme, as both a benefit and a determinant of being able to individualise their
approach.107,111,112,117,121,125,132,134,135,138
The involvement of family members was also key to personalising care107,136,142 and a source of mutual
appreciation and respect.121,127,142 A number of studies described successful approaches to stimulate
collaboration between relatives and staff.111,114,122,125,141
Challenges to a successful intervention
A number of challenges were identified, many of which related to the additional work, the requirement for
flexibility of team rotas111,136,142 and low levels of staffing as significant barriers to implementation.119,120,136,140,142
However, with the exception of two studies,126,134 the benefits conferred were thought to over-ride the
difficulties.111,120,136,140,142
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The wide range of staff responsibilities and reporting requirements were frequently cited as a barrier
to the implementation of psychosocial approaches.119,133 Staff reported a perceived pressure to focus
on responding to challenging behaviour, physical care and safety, rather than supporting individual
interactions.106,115,119,134,138
Finally, a number of challenges were described regarding negative attitudes towards psychosocial
interventions and a general lack of knowledge about their potential benefit.111,126,129,134,142
Discussion
Overall, the metasynthesis identified how important positive benefits from psychosocial interventions
can be achieved. The major learning outputs that were taken forward were as follows:
l It is critical to involve staff and care home managers as active participants and to ensure that they
have personal investment in the intervention through collaborative, sympathetic approaches that
openly accept the burden and challenges that they experience.
l Buy-in by family members is also critical – workshops and group events are effective in
promoting this.
l Flexibility is an essential aspect – ensuring that the intervention is adaptable to different home
structures and staffing levels, and tailored to resident abilities and interests.
l Organisational support is required to sustain learning and change in practice, particularly given that
training and mentoring involve considerable time investment by staff. It is important to make a clear
health economics argument to support this.
l Cultural change is required to encourage staff to think about residents individually and to address
concerns about a new intervention alongside identifying benefits.
l Person-centred care is fully accepted as the framework for intervention, with established means of
tailoring interventions to an individual’s needs.
l Training is critical and particularly effective when it includes scenario-based, interactive elements
and the opportunity for staff to reflect on their practice.
Limitations
Qualitative metasynthesis offers a systematic, relevant overview of international qualitative research,
while retaining much of the detail that individual studies provide. However, there is a risk that synthesising
across qualitative studies could compromise the integrity of the individual projects, as well as their
emphasis on context and holism.98 We are mindful that this review identified a heterogeneous set of
studies that varied in care setting, intervention type and methodological design. To convey the context
of the study, comprehensive details are published in Lawrence et al.100
We also recognise that the sample size is large for a metasynthesis, but are satisfied that the scope of
the review was sufficiently focused and believe that the range of data assisted in identifying the
properties and key concepts that can be applied across groups and settings.
Implications for the WHELD programme
The recommendations outlined above were taken forward to the intervention development phase of
WP2 (described below). The identification of key elements of successful interventions, combined with
the outputs of the review in WP1, indicated the need for incremental evaluation of individual elements
of psychosocial interventions to enable an examination of the breadth of their benefits.
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The WHELD therapy development
Rationale
The work completed in WPs 1 and 2 provided a comprehensive picture of the requirements and
existing resources that are available for the creation of an optimised person-centred care intervention.
The next phase of the work sought to operationalise this information through a period of collaborative
development work with a TDG and associated expert panel.
Aim and objectives
The aim was to develop an optimised person-centred care intervention for people with dementia living
in care homes, which would include a training programme for care staff.
Specific objectives within this aim were to:
l co-ordinate a large-scale expert consultation and TDG to gather informed opinion on the most
appropriate design and content for the WHELD programme
l operationalise the WHELD programme by developing a manual for use in care homes
l finalise the design of the evaluation of the WHELD programme for WP3.
Methods
Selection and scrutiny of the interventions
During October and November 2010, a TDG was convened that consisted of the WHELD investigators,
lay representatives and care home experts, including providers and inspectors.
The expert panel reviewed existing programmes that had evidence of efficacy, to identify elements
to be included in a person-centred care programme. The FITS28 and NEST,29 including the Simple
Pleasures90 and Improving Dementia Care,30 interventions were scrutinised to identify which elements
had proven to be the most effective, which could also be combined into a consistent conceptual
framework for person-centred care. The manuals were also reviewed against the emerging literature
identified in WP1 and the metasynthesis in WP2. The language and style of the interventions were
reviewed, with consideration of the UK context of delivery.
Expert consultation: workshops
A series of workshops was co-ordinated to gather opinions and experience from a wide audience. In
total there were 89 workshop participants, including national and international experts from research
backgrounds; clinicians from nursing, occupational therapy, physiotherapy, clinical psychology and
psychiatry; care home managers and practitioners; and family carers. Two group workshops were
conducted with 40 participants in each group to achieve a robust consensus.
The meetings commenced with a presentation of work from WP1 and an overview of the evidence
base. Participants were asked to consider the evidence and provide recommendations regarding the
selection of interventions to include in the WHELD programme. In a second session, participants
developed recommendations for refinement of the person-centred care training that was outlined in
the FITS programme,28 to improve implementation. Suggestions were prioritised by consensus, working
to create a list that informed the manual development for the intervention.
Intervention creation
The TDG collated and operationalised the outcome of the expert panels to produce the WHELD
programme. Manuals of the four selected interventions and overall protocol were produced. Members
of the TDG also liaised with three key external experts (Linda Buettner, Jiska Cohen-Mansfield and
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Linda Teri) regarding their existing interventions and how they might be adapted for the WHELD
programme.29,31,37 The formative materials were then edited to reflect UK practices where necessary.
When there was overlap between materials, a decision was made based on the workshop feedback
about which material would best meet the criteria for being effective and feasible for a UK care home
setting. The full intervention was circulated to all WHELD study investigators for comment and, finally,




Four key interventions were to be used within the WHELD programme (person-centred care training
for staff), which acted as the underpinning framework for the delivery of all interventions, social
interaction, physical exercise and review of antipsychotic medication.
Four existing evidence-based interventions were identified for the adaptation to create the WHELD
programme. These were the FITS person-centred care manual,28 a non-drug protocol focusing on
pleasant activities,37 the NEST intervention29 and the Seattle Protocols.35 Specific recommendations
were made for refinements to individual elements based on safety and UK context-specific
considerations.
Adaptation of interventions for the WHELD programme
The TDG developed a manual of the four interventions and the overarching delivery protocol, which
are outlined below.
Person-centred care training for staff
This intervention combines elements of several effective interventions that promote person-centred
care. These included the FITS person-centred care training package28 and opportunities for experiential
learning about adapting care practice to meet the needs of someone with dementia. Using residents’
life stories was a foundation to understand individuals’ needs and preferences. A structured
assessment of unmet needs29 underpinned positive individualised care planning by using specific,
measurable, achievable, relevant, time-bound (i.e. SMART) goals to implement activities based on a
person’s preferences.90
Review of antipsychotic medication
Previous studies28 that have achieved a reduction in antipsychotic use have incorporated a formal review
of antipsychotic medications according to standardised protocols. The National Service Framework
recommend that reviews take place every 3 months. The TDG agreed that a review would be undertaken
using best practice guidelines for the prescription of antipsychotics to people with dementia.27 The aim
was for care staff to understand the need for regular review and develop a process that was led by the
care home that enabled this to be undertaken by the resident GPs. Workshops were also designed for
GPs to support care staff in following the best practice guidelines.
Social interaction
This intervention was based on the Positive Events Schedule, the NEST intervention, the Seattle
Protocols and Cohen-Mansfield’s ‘toolbox’ of psychosocial interventions, which were individualised to
the needs of a particular individual.29,35,144,145 A version of the ‘toolbox’ approach had been evaluated in
several small pilot studies, as well as in a large, open, 4-week trial as part of the CALM-AD clinical
trial146 and as part of the FITS study.28 Activities promoting social interaction were adapted for a UK
care setting, with the aim that the activities should be delivered for 60 minutes per week or that there
would be a 20% increase in activity if the resident already engaged in this level of activity.
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Exercise
The RDAD programme,147 which focuses on activities, strength, balance and flexibility training, was
identified as the best evaluated programme for people with dementia, showing significant benefits for
activity, mood and health in a RCT.31 RDAD exercises were adapted to be simply and safely delivered
by care staff who had no formal physiotherapy or exercise training. Walking or pleasant activities of
the residents’ choice, including seated exercise or circle dance, were incorporated from the exercise
section of the NEST protocols.29 The aim was that this should be delivered for 60 minutes per week or
that there would be a 20% increase in activity if the resident already engaged in this amount of exercise.
Operationalisation of the WHELD programme
The TDG produced a manual for the delivery of the WHELD programme as an incremental intervention
for evaluation. The delivery was designed as a training programme that was co-ordinated by a central
WHELD therapist, who then provided support and supervision for care home staff. Care homes also
nominated WHELD dementia champions to act as internal mentors who had responsibility for the
implementation of interventions within the care homes. The TDG, therefore, produced one detailed
therapist manual, which provided detailed information on the delivery of each intervention, and one
dementia champion manual, which was for care home staff. The manuals aimed to maintain distinctiveness
between the elements that were delivered, but did not preclude homes from developing activities and
interventions of their own volition.
Discussion
The work completed in WP2 follows a clear pathway, from a theoretical basis through a conceptual
framework to a tangible operational intervention. The WHELD programme represents a synthesis of
knowledge that is drawn from clinical trial data, existing resources and qualitative analysis, and is
collated for use by a broad expert consensus process.
Concluding remarks for work package 2
Work package 2 successfully collated evidence from different sources, including systematic reviews,
qualitative reviews, expert consensus and existing operationalised interventions, to prioritise interventions
for the new WHELD programme. The large consensus process gives additional validation to the final
intervention, which was taken forward for evaluation in WP3.
Major outputs of work package 2
The WHELD programme materials
The major outputs of WP2 were the WHELD Therapist Manual and the WHELD Dementia
Champions Manual.
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Work package 3: factorial pilot evaluation
of non-pharmacological interventions in
combination with person-centred care
training in care homes
Abstract
Objectives: To establish the feasibility, effectiveness and cost-effectiveness of person-centred care
training for care staff alone and in combination with antipsychotic review, social interaction
and exercise.
Methods: A 9-month, cluster, factorial RCT of the WHELD programme in 16 care homes. All care homes
received person-centred care. Eight care homes were randomly assigned to receive antipsychotic review,
social interaction or exercise. The primary outcome measure was antipsychotic use. Secondary outcome
measures were BPSD and mortality. The costs of care were defined and cost-effectiveness was analysed
using the Client Service Receipt Inventory (CSRI). Focus group discussions with staff talked about their
expectations.
Results: Antipsychotic review reduced antipsychotic use by 50% [odds ratio (OR) 0.17, 95% CI 0.05
to 0.6]. Antipsychotic review plus social interaction significantly reduced mortality but increased BPSD
compared with receiving neither antipsychotic review nor social interaction (score difference 7.37,
95% CI 1.53 to 13.22). This detrimental impact was mitigated by concurrent delivery of social interaction
(–0.44, 95% CI –4.39 to 3.52). The exercise intervention significantly improved neuropsychiatric
symptoms (–3.58 symptoms, 95% CI –7.08 to –0.09 symptoms) but not depression (–1.21, 95% CI
–4.35 to 1.93). The focus groups emphasised that successful training must acknowledge and respond
to ‘whole-home’ issues.
Conclusions: Person-centred care, antipsychotic review and social interaction showed benefit to QoL,
antipsychotic use and mortality and have indications of cost-effectiveness.
Background and rationale
The work that was completed in WPs 1 and 2 of the WHELD programme builds on a growing body of
literature.32 Our meta-analysis showed the benefit conferred by social interaction and pleasant activities
on both BPSD and antipsychotic use,43 and of physical activity through personalised exercise on mood.31
This suggested that augmented person-centred care with social interaction, pleasant activities and
physical activity would be effective.
Until 2008, cohort studies and audits in the USA and Europe reported that 40% of people with dementia
in care homes were receiving an antipsychotic drug.148–150 In recent years, the concerted effort to reduce
unnecessary prescribing has led to a 15–50% reduction in prescriptions of antipsychotic drugs across the
USA and Europe.23–25 Although recent randomised antipsychotic discontinuation studies have reported
benefits following the withdrawal of antipsychotics,16 there have been no randomised trials of rigorous
antipsychotic review.
Working papers detailing the work plan and analysis plan are in Appendix 1.
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Aim and objectives
Work package 3 reports a factorial evaluation of the WHELD programme, to evaluate the effectiveness
of person-centred care training for care staff alone and in combination with antipsychotic review, social
interaction and exercise interventions.
Factorial randomised controlled trial of the WHELD programme
Rationale
Our work had raised clear questions regarding the potential to build an effective, feasible real-world
intervention to manage antipsychotic use and BPSD in care homes.
Hypotheses
l Person-centred care plus antipsychotic review will result in the reduction of programme prescribing.
l Person-centred care and social interaction will result in reductions in BPSD, particularly agitation
and aggression.
l Person-centred care and exercise will improve mood.
Methods
Full details of the methodology for WP3 are published in outputs.151–153
A 9-month, cluster, factorial RCT of the WHELD programme in 16 care homes was carried out.
All care homes received person-centred care. Eight care homes were randomly assigned to each of
antipsychotic review, social interaction or exercise, so that 2 of the 16 homes had each possible
combination of treatments. The eight care homes that were assigned to each type of intervention
(factor) were compared with the eight care homes that were not assigned to that intervention (factor),
to determine the impact of each intervention. A further analysis was undertaken to examine whether
or not there were any additional benefits of receiving more than one type of intervention.
Inclusion criteria
The participants were people with dementia, as defined by the Clinical Dementia Rating (CDR)154
(i.e. a score of ≥ 1) and Functional Assessment Staging (i.e. a stage ≥ 4).155
Interventions
Person-centred care The person-centred care intervention used tools that were developed for the
FITS programme.28 Supplementary materials were drawn from the best available training manuals32
and were augmented by leadership training using principles from our systematic qualitative review.100
Antipsychotic review Antipsychotic prescriptions were reviewed by primary care physicians or
psychiatry specialists, based on existing guidance.7,27
Social interaction with pleasant activities The objective was to use the evidence-based protocols that
were described in WP2 to provide 1 hour of social interaction per week for each resident, through
positive, planned social interactions. Personalised activities were developed based on conversation
with each resident, their life history and interests, to ensure that the activities and interactions were
individually tailored. The aim was to enhance resident interactions with staff, family and volunteers,
which were delivered through individual or group sessions based on their preferences.29,31,37
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Exercise Exercise was promoted through enjoyable physical activities based on published approaches.29,35
Assessment of the resident’s interests informed a personalised exercise plan that was developed by the
therapist and the champion, accounting for health and fitness levels.
Outcome measures
The primary outcome measure was antipsychotic use, which was recorded according to the British
National Formulary156 classification.
Secondary outcome measures were:
l depression – measured using the Cornell Scale for Depression in Dementia157
l agitation – measured using the 29-item CMAI158
l BPSD – measured through the 10 domains of the Neuropsychiatric Inventory, care home version
(NPI-NH)159
l health-related QoL –measured by the Dementia Quality of Life Scale (DEMQoL) – Proxy.160,161
Mortality
The severity of dementia was measured by the CDR154 and the Functional Assessment Staging
instrument.155
All assessments were undertaken based on informant interviews with members of care home staff,
which were conducted by trained members of the WHELD programme research team.
It should be noted that there are some differences between the secondary outcomes that are reported
in the protocol and the secondary outcomes that are described in the narrative of the text and reported
in papers. As stated in the protocol, mental health (depression, agitation, overall neuropsychiatric symptoms
and apathy)151,162 and QoL were also reported as secondary outcomes in line with the protocol.153
Physical morbidity was complicated and inconsistently described; therefore, we adopted mortality as
a secondary outcome as a proxy for severe physical morbidity. Mortality is presented in the text and
in a published output.151 Falls was another secondary outcome in the protocol; this was inconsistently
reported and, therefore, we did not feel that falls could be reliably included in the report. The coding
complexities of recording non-antipsychotic psychotropic medication made it difficult to incorporate
a meaningful analysis in the trial report; however, we have made these data available to an ongoing
NIHR systematic review. One of the original goals was to also examine mediating factors that are
related to delivery implementation. The large number of data made this impractical, but it was routinely
used to guide supervision and improve the fidelity of intervention delivery. These changes were approved
by the Trial Steering Committee (TSC).
Power calculation
Based on PASS 11 Version 11.0.10 2012 (NCSS, Kaysville, UT, USA) (power analysis and sample size
software) sample sizes, 96 in each group would give 82% power to detect a difference between the
two proportions of –0.20. The test statistic used is the two-sided z-test to compare two independent
proportions for a cluster randomised trial in which the intracluster correlation is assumed to be 0.05.
The significance level of the test is 0.05. After adjusting for a drop-out rate of 25%, the sample size
required was 128 per trial arm or about 16 participants per home. Based on the ES (> 0.50) seen in
the Caring for Aged Dementia Care REsident Study (CADRES) study,30 the study was designed to detect
an ES of 0.5 for the other outcomes. A total of 128 participants for each of the group comparisons gives
80% power to detect a treatment difference at a two-sided 0.05 significance level, if the true ES is 0.5.
Cluster randomisation reduces efficiency and leads to loss of power but was essential, as the intervention
has to be implemented throughout individual care homes. The design effect, otherwise known as the
inflation factor, is defined as the ratio of the total number of participants required using cluster
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randomisation to the number of participants required using individual randomisation. Statistical theory
leads to the following formula:
Design effect = 1 + ½(m− 1) × r1, (1)
r1 = s2b / (s2b + s2w), (2)
called the intracluster correlation coefficient (ICC), where s2b is the between-cluster variance and
s2w is the within-cluster variance. ICCs for authentic resident outcome measures (rather than process
outcomes) rarely exceed 0.03. An estimated average of 16 eligible participants per cluster leads to an
inflation factor of 1.45. Therefore, 186 partipants were required to give this level of power for each
outcome. Given the frailty of the population and the estimated mortality rate, a total sample size of
240 participants was stipulated to allow for mortality and dropout. This sample size does not give
power to correct for multiple testing with respect to the three primary hypotheses.
Statistical analysis
Analyses accounted for intervention, baseline demographic and clinical characteristics, and site as
covariates and exposure variables. The analysis used multiple linear regression models for continuous
outcome measures and logistic regression models for binary outcome measures.163–165
The primary outcome was an intention-to-treat analysis, with age, gender and severity of dementia
included as covariates.
Although our protocol paper does not document our planned between-group analyses, it was always
the intention to report these analyses. The prespecified primary outcomes for each comparison of
antipsychotic review, social interaction and exercise were antipsychotic use, agitation and depression,
respectively. Of the three comparisons, we were in greatest need of statistical power for the antipsychotic
outcome. Therefore, we sought a sample size of 96 participants per group to show a 20% difference in this
outcome with 82% power.
This approach was approved by the TSC. The statistical analysis plan was agreed by the TSC, Data
Monitoring Committee and trial statistician prior to data lock. The statistical analysis plan is available
in Appendix 1.
Results
Factorial randomised controlled trial
The main factorial study demonstrated that antipsychotic review significantly reduced antipsychotic
use by 50% (OR 0.17, 95% CI 0.05 to 0.60). The intervention of antipsychotic review plus social
interaction significantly reduced mortality (OR 0.26, 95% CI 0.13 to 0.51) compared with the group
receiving neither antipsychotic review nor social interaction; however, the antipsychotic review plus
social interaction intervention showed significantly worse outcome in neuropsychiatric symptoms than
the group receiving neither of these (score difference 7.37, 95% CI 1.53 to 13.22). This detrimental
affect was mitigated by concurrent delivery of the social intervention (mean difference –0.44, 95% CI
–4.39 to 3.52). The exercise intervention significantly improved neuropsychiatric symptoms (mean
difference –3.58, 95 % CI –7.08 to –0.09) but not depression (mean difference –1.21, 95% CI –4.35
to 1.93). None of the interventions had a significant impact on agitation specifically. The cohort
characteristics and results are described in detail in published outputs.151,166
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Additional economic analysis
An economic analysis was conducted using baseline data to understand the main cost drivers for people
with dementia in care homes. This was an additional output that was not stated in the hypotheses.166
Discussion
The WHELD programme conferred a significant 50% reduction in antipsychotic use, even in a population
with a baseline antipsychotic use < 20%. Exercise conferred significant benefits to overall BPSD. In
addition, the group who received antipsychotic review in combination with social interaction had a
significant reduction in mortality. Social interaction alone also conferred benefit to health-related QoL.
The detrimental affect of antipsychotic review on BPSD and health-related QoL was an important
finding, which was probably explained by the changed landscape of antipsychotic prescribing.17,23–25
The antipsychotic review intervention was based on guidance that was created before the substantial
reductions in antipsychotic use over the last 5 years.27 Although this has achieved significant benefits,
it has meant that the severity of BPSD in people who are now receiving antipsychotics is probably
much higher than it was previously.
The mortality figures also have important implications, particularly given that mortality risk has
been a key driver in the campaign to reduce antipsychotic use.15 Although antipsychotic review
alone reduced mortality by > 30%, this became statistically significant only in combination with
social interaction.
Implications for the WHELD programme
Work package 3 clearly demonstrated the feasibility of the WHELD programme to reduce
antipsychotic use in people with dementia and suggested the potential for benefit in QoL.
Qualitative analysis: implementation of psychosocial interventions
in care homes
Rationale
This qualitative analysis collated the opinions of care home staff about the interventions and their view
on the most effective means of implementing psychosocial interventions. The aim was to glean practical
and theoretical factors that could then be integrated into the WHELD programme and optimisation
in WP4.
Methods
Focus group discussions were conducted with care home staff prior to the factorial study. Purposive
sampling was conducted to obtain the perspectives of staff in a variety of roles who had a range of
experience and expertise. Focus group discussions were held with 8–12 members of the care team,
where possible, to explore successful working practices, challenges and priorities within the care home,
as well as specific attitudes and beliefs surrounding psychosocial interventions and the support that
would be required to deliver them. The discussions were recorded and transcribed verbatim, and
observations and impressions were routinely noted at the end of each group. Transcripts were
subjected to thematic analysis through the constant comparison method.167
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Results
Participants in the focus groups comprised 53 care assistants (45%), 30 senior care assistants (25%),
13 activity therapists (11%), six registered nurses (6%), five deputy managers (4%), two managers (2%)
and 10 other staff (8%). Three key themes emerged: ‘undervalued and understaffed’, ‘centrality of
relationships’ and ‘existing practices and desire for support’.168
The work related to the implementation of a specific social activity was published as a separate report.169
Discussion
The outcomes of the thematic analysis emphasised the importance of acknowledging ‘whole-home’
issues, such as environmental, care practice and attitudinal factors.28 A collaborative approach that
seeks the views of staff from the outset provides positive feedback, does not judge past or present
care practices and offers an effective method of engagement.170 The work revealed optimism among
staff that the training programme might, first, enhance their status among relatives, managers and
care commissioners and, second, encourage these parties to commit greater resources to delivering
psychosocial care.
The review of non-pharmacological interventions conducted in WP2 chimes with the findings of this
WP, indicating the critical barrier of limited resources in care homes.171
The expressed enthusiasm for one-to-one time with the residents is a positive outcome that could be
fostered to promote person-centred care and job satisfaction.172 Research elsewhere has indicated
that the more staff relate to residents as individuals, the less they perceive difficult behaviour as
challenging.173 However, training and support interventions need to acknowledge that empathising
with residents and becoming involved in their lives can contribute to burnout if not accompanied by
appropriate support.174 Participants cited the value of peer support in this respect. More generally, the
importance of teamwork in improving quality of care is well documented,175 as is the role of leadership
in promoting communication and relationships among staff.176 Training and support programmes need
to recognise the impact of these dynamics and assist managers to promote information flow among
staff, facilitate inclusive discussions about care delivery, incorporate diverse points of view and build
positive relationships among all those living and working in the care home.177 This should extend to
family members, who were frequently criticised for being unduly critical of staff.178
Implications for the WHELD programme
Qualitative work conducted with care staff clearly demonstrated the need to involve the entire
staff team in any new intervention to have complete ‘buy-in’, as well as ensuring that trainers fully
acknowledge the cultural and resource challenges inherent in care home settings and strive to work
with staff to overcome them.
Concluding remarks for work package 3
Work package 3 was successfully delivered and demonstrated an impact on QoL, antipsychotic use
and mortality with the combination of person-centred care, social interaction and antipsychotic review.
These, therefore, appeared to be the key components to integrate into a single optimised intervention
in WP4.
The qualitative work provides clear insights into the needs for delivery of the intervention to support
future implementation. In practical terms, this includes effective supervision and support for therapists
to enable ‘on-the-job’ learning, and an understanding of the drivers for motivation and engagement
among care home staff.
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Based on qualitative feedback from this WP and WP4 (see Work package 4: evidence-based and user-driven
optimisation of the WHELD programme for use in a real-world setting), the decision was made to develop a
lower cost champion model for intervention delivery.
Success indicator
One of the care homes involved in the factorial study won Care Home of the Year at the National
Care awards for the year that the home was involved in the WHELD programme.
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Work package 4: evidence-based and
user-driven optimisation of the WHELD
programme for use in a real-world setting
Abstract
Objectives: WP4 sought to optimise the WHELD programme through a series of review and
consultation steps.
Methods: WP4 involved (1) review of the outcomes of WP3 with expert and governance groups,
(2) review of the study materials and their usage with WHELD programme therapists and (3) focus
group discussions with 41 care staff who were involved in the factorial trial in WP3 to understand
their experience of involvement in research and use of the WHELD programme. The intervention was
then refined according to the outputs.
Results: A number of key changes were made to the intervention. The optimised intervention consisted
of person-centred care and social interaction, with activities elements from the exercise package and
a cascade version of the antipsychotic review intervention in which staff prompted GPs for review.
The delivery model was adapted for implementation and cost-effectiveness, replacing intensive therapist
time with a champions model. The focus group discussions relating to both the overall research experience
and the use of WHELD materials reported a generally positive experience for staff, and beneficial aspects
of WP3 were identified. However, there were issues identified in relation to the extra burden of data
collection for research and the perceived pressure of time to deliver the intervention alongside routine
care activities.
Conclusions: The adaptations of the intervention and protocols ensured that the WHELD programme
was fit for full evaluation in WP5.
Background and rationale
The factorial trial completed in WP3 provided robust, meaningful data regarding the value of the four
elements of the WHELD programme, in addition to critical information regarding the most valuable
outcome measures for a full evaluation and the importance of user involvement in intervention
development.
This work was completed in the context of a considerable literature and academic consensus that
supports the need and rationale for an intervention that draws together the best available interventions
to create an optimised ‘real-life’ approach, which is both effective and feasible for implementation. WP3
provided key evidence of effectiveness, but showed the need to optimise the intervention further to
ensure that it could be feasibly rolled out. A critical factor in this was the need to involve end users in
the refinement process. Existing literature consistently reports the need for a collaborative approach that
seeks the views of staff from the outset, provides positive feedback, does not judge past or present care
practices and offers an effective method of engagement.170
Cost-effectiveness is also a critical aspect in the prospective success of any health service intervention,
particularly in the care sector, in which resources are limited and there is considerable competition
for commissioning. This aspect was clearly shown in the cost–function analysis performed in WP3,
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which indicated the need to integrate meaningful cost-effectiveness measures into large-scale trials,
as well as improving needs-based care for people with dementia.
Work package 4, therefore, collated the findings of the programme to date, and consisted of a
collaborative final optimisation stage to create a final WHELD programme described in a manual for
full evaluation in WP5.
Aim and objectives
The overall aim of WP4 was to optimise the overall WHELD programme for full RCT evaluation.
This was achieved through the following objectives:
l conduct a review of the materials used in WP3 and collate learning points from supervision
conducted with WHELD therapists regarding feasibility of intervention delivery
l conduct a consultation with key groups (PMG and TDG) to agree on the requirements for
adaptation of the WHELD programme
l conduct a series of focus group discussions with care staff, with the aim of ensuring a collaborative
approach to the intervention optimisation
l adapt the intervention manuals to reflect the approved amendments.
Methods
Review of use of WHELD programme materials
A full review of the WHELD manuals was conducted by a subgroup of the PMG. The review focused
on determining where resources could be adapted and combined as a means of streamlining the
intervention. This process involved three main steps:
1. reviewing feedback from therapists collected during the factorial study in WP3
2. collation of notes taken during supervisions with WHELD therapists in WP3
3. co-ordination of an end-of-study meeting with therapists who were involved in WP3.
Consultation with expert groups
Expert consultation was conducted in two ways. First, a meeting was convened with the PMG,
in which the study statistician presented the statistical outputs from the factorial trial in WP3. The
group then discussed the implications for the recruitment strategy and intervention design, and made
recommendations for refinement. Second, consultations were conducted with selected members of
the TDG (specifically Professor Dawn Brooker, Professor Graham Stokes and care home managers).
These discussions focused on the most effective way to streamline the intervention to make it
deliverable in a real-world setting. The outputs of these consultations were collated and used to
inform the intervention optimisation.
Focus group discussions with care staff
Six focus group discussions were conducted with 41 care home staff, who were selected from six of the
care homes (two from each site) from the factorial trial in WP3. The focus group discussions aimed to
explore staff’s experiences of being involved in a research trial and which elements of the research and
intervention they felt had been successful. The discussions also explored any unhelpful or challenging
aspects and any learning points for staff members. Focus group discussions were recorded and
transcribed verbatim; observations and impressions were noted at the end of each group. Inductive
thematic analysis was used to identify themes and interpret the data.
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Intervention optimisation
The outputs of the consultation and focus group discussions were collated by two investigators
(CB and JF) and one therapist (LG). This subgroup adapted the existing manuals from each individual
intervention element to create the optimised WHELD programme manual.
Results
Review of materials in work package 3
Review of the patterns of usage and therapist feedback regarding the WHELD programme manuals
and resources highlighted key points for adaptation. These were:
l The need to emphasise the purpose of the materials to be used as templates for adaptation by
individual homes according to their processes and structures. It was felt that homes had not fully
appreciated this flexibility in the resources.
l The adaptation of the language and terminology in activities derived from the NEST manual, which
required further adaptation for a UK audience.
l A number of NEST manual activities had not been used as a result of the perceived cultural
differences in UK settings. These were recommended for removal.
l Staff time required to set up and deliver interventions was highlighted as an important factor in the
likelihood of the usage of these activities. Time-intensive activities were deprioritised in favour of
less intensive options.
l Staff skills in delivering group activities were reported to often be lacking. Improved training and
support in developing and applying these skills were, therefore, prioritised.
l Peer support and supervision for the WHELD programme therapists was highlighted.
Feedback clearly described the need for a launch event at each care home to ensure that there was
buy-in and engagement of all staff, and to promote motivation within the study. Certification of
training and involvement was also considered to be a driver for continued engagement.
Consultation with expert groups
The PMG discussion resulted in three main recommendations for optimisation of the WHELD programme.
These were:
1. To retain the social interaction intervention as a key element owing to the significant benefit
conferred in the factorial study.
2. To include a reduced selection of activities taken from the exercise intervention as part of the
pleasant activities component of the social interaction intervention.
3. To reduce the focus on intensive antipsychotic review due to the negative impact on BPSD. The
group recommended that all participants should be reviewed, but that this should be prompted by
trained care staff. The group suggested that the active GP education element of the intervention
was removed to ensure that the intervention was streamlined for a real-world setting.
The consultation with members of the TDG resulted in one main recommendation that related to
the implementation and delivery of the intervention. The group agreed that, although it provided
consistency and support, the delivery model utilised in WP3, in which a therapist provided training
and intensive support, was highly resource intensive and, therefore, not feasible or cost-effective for
a real-world setting. To provide an intervention that required less intensive support from the WHELD
therapist, the dementia champions role was extended, with more emphasis on a ‘train-the-trainer’
model with supervision from the therapist. This approach has been increasingly used in practice in
recent years, and is regarded as cost-effective and a means of skill-building within services, although
published evidence is limited.
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Focus groups with care staff
Focus group discussion demographics
Six focus groups involving 41 staff were conducted across 6 of the 16 care homes in the UK that had
participated in a 9-month RCT of psychosocial interventions for people with dementia, as described in
WP3. Participants included 24 care assistants (59%), six senior care assistants (15%), five activity
therapists (12%), one registered nurse (2%), two managers (5%) and three housekeeping staff (7%).
The time they had spent working at the home ranged from 3 months to 20 years, with the median
being 12 staff who had worked in the home for 3–5 years. In total, 41% of staff reported no formal
care qualification, 20% had their highest level of National Vocational Qualification (NVQ) at level 2 and
24% at NVQ level 3.
Thematic outcomes related to the WHELD research aims and process
The focus group discussions were transcribed verbatim and analysed using thematic analysis. This led
to the identification of three key themes relating to the research experience: ‘recognising preparedness’,
‘working together’ and ‘learning more than expected’. These are detailed in a published output.179
The learning for the research team in relation to optimising the approach and materials for WP5 is
summarised here. The majority of staff felt that the study had value and was a good means of raising
the profile of dementia care practice. The research team reported that it had been valuable to include
a range of staff because of the differing perceptions of care between staff seniorities and shifts,
particularly including both day and night staff. Staff also felt that it had been valuable for the WHELD
therapist to get to know the home in the early phase of the study and be able to respond to the staff’s
hopes and concerns about the research. Knowing residents’ needs was key to being able to implement
the ideas, and could be best achieved by care staff themselves. Some of the WHELD materials were
highlighted as being particularly helpful in facilitating staff to collect and record information about
residents. In terms of the process of delivery, focus group discussions highlighted the benefits of the
therapist working alongside dementia champions in the care homes for a sustained period to build
trust and confidence in adopting the WHELD approach.
Staff appreciated feedback and positive affirmation of their good practice and had found this motivating
in several respects, including the development of person-centred protocolled activities. In addition, staff
felt that they developed skills in team working and educating colleagues, involving residents’ families
more actively in care planning and in systematically recording information. Families’ knowledge was
highlighted as particularly valuable in understanding a resident’s distress and in helping to resolve
challenging situations.
Staff reported some barriers to effective person-centred care. Situations were described in which staff
opinions of best practice conflicted with family wishes and their understanding of dementia, and staff
believed that some families were reluctant to be closely involved with activities. Despite this, instances
were also identified in which family involvement had been helpful. This theme demonstrated a need to
provide better operationalisation for family working in the WHELD manual. A second issue in person-
centred care was the involvement of volunteers. Conflicting views were held regarding the benefit of
additional capacity balanced with the burden of increased administration and support from staff.
The social interaction and exercise interventions were described positively by staff, although time
constraints were cited as a considerable barrier, in addition to the reluctance of residents to take
part on occasions. Staff reported that it was, therefore, very helpful that the goals for recommended
activity time were weekly, allowing for flexibility. These were regarded as helpful, realistic and
achievable, and staff clearly articulated their understanding of the value of the approach. Several staff
also reported that taking part in the activities had been personally rewarding and benefited residents,
with identifiable positive emotional and personal impacts.
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Focus group discussions were positive about the antipsychotic review intervention, showing an
understanding of the importance of judicious antipsychotic use. Staff particularly valued the closer
working with GPs and felt that this collaboration worked well in that it motivated staff to be more
proactive in this aspect of the residents’ care.
Refinement of intervention protocol
Two investigators (CB and JF) and a WHELD therapist (LG) optimised the intervention manual to
reflect the recommendations from the consultations. This involved combining the individual manuals
for person-centred care, social interaction and exercise into one WHELD therapist manual. The work
also involved the creation of a new WHELD champions manual to support the new delivery model.
The newly adapted manuals and associated protocols were circulated and approved by all members of
the PMG.
Finalisation of the randomised controlled trial protocol
Based on the evidence in the three review activities, refinements were made to the protocol for the
future RCT evaluation of the WHELD programme and were approved by the PMG. These included:
l The success of recruiting care homes in WP3 confirmed the feasibility of a ‘cold contact’ approach
to recruitment directly from Care Quality Commission registers.
l Recruitment protocols were adapted to use a stepwise approach across geographical areas within
each site to be more timely and cost-effective. A care home demographic screening questionnaire
was included earlier in the recruitment process. Home information was adapted to provide clarity
on the time commitment involved for homes.
l The number of assessment measures was reduced by removing the Camberwell Assessment of
Need in the Elderly (CANE) scale from the protocol. Detailed process monitoring with WHELD
therapists in a larger RCT was not feasible. For this reason, a qualitative package was planned in
WP5 to capture this information and to reduce burden on the therapists.
Discussion and implications for the WHELD programme
Work package 4 drew on consultations with a range of stakeholders who had been involved in WP3 to
understand how best to adapt the intervention, delivery model and evaluation protocol. It was important
to consider the overall experience of staff in the whole research process in recognition that these
elements may have an indirect impact on staff motivation and effectiveness in engaging with the project.
This approach proved helpful in triangulating information about which elements had been effective and
which required revision, both from a process and a content perspective. The resulting adaptations of the
intervention and protocols ensured that the WHELD programme was fit for full evaluation in WP5.
Limitations
This work was pragmatic and resulted in an optimised intervention for WP5. However, it would
have been helpful to engage with residents and family members directly about their experiences.
Unfortunately, owing to the nature of the intervention delivery and the extent of impairment of
residents, this was not deemed feasible within the scope of WP3 or WP4.
Concluding remarks for work package 4
This was a largely operational WP, combining consultation with key groups with a period of refinement
and optimisation of the WHELD programme. The process followed by the investigator team resulted in
a fit-for-purpose intervention portfolio and trial protocol. This fulfilled the stated objectives of the WP.
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Of note, this WP particularly benefited from user involvement and patient and public involvement (PPI)
throughout, ensuring that the various discussions and alterations were directly informed by stakeholder
feedback and opinion.
Major outputs from work package 4
l Final WHELD programme manual.
l Final WHELD champions manual.
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Work package 5: randomised controlled
trial and field testing of the WHELD
programme in care homes
Abstract
Objectives: WP5 aimed to establish the clinical effectiveness and cost-effectiveness of the optimised
WHELD programme and to determine factors influencing sustainability for use in UK care homes.
Methods: This was achieved through (1) a large RCT of the optimised intervention compared with
usual care; (2) an integrated cost-effectiveness analysis of the optimised intervention; (3) a qualitative
analysis of WHELD materials that were used by WHELD therapists and supervisors to determine
factors that are associated with successful implementation; and (4) a qualitative analysis with care
home staff to determine the sustainability of the WHELD programme.
Results: WP5 successfully delivered a robust and rigorous clinical evaluation of the optimised
WHELD programme utilising a champion’s model. The intervention conferred a statistically significant
improvement in QoL [DEMQoL – proxy z-score of 2.82, mean difference 2.54, standard error of
measurement (SEM) 0.88, 95% CI 0.81 to 4.28, Cohen’s d ES of 0.24; p = 0.0042]. There were also
statistically significant benefits on agitation (CMAI z-score of 2.68, mean difference –4.27, SEM 1.59,
95% CI –7.39 to –1.15, Cohen’s d ES of 0.23; p = 0.0076) and overall neuropsychiatric symptoms
(NPI-NH z-score of 3.52, mean difference –4.55, SEM 1.28, 95% CI –7.07 to –2.02, Cohen’s d ES of
0.30; p < 0.001). Benefits were greatest in people with moderately severe dementia.
Conclusions: These findings suggest that the WHELD programme confers benefits to QoL, agitation
and neuropsychiatric symptoms, albeit with relatively small ESs, as well as cost saving in a model that
can readily be implemented into nursing homes. Future work should consider how to facilitate
sustainability of the intervention in these settings.
Background and rationale
Work package 5 represents a culmination of extensive evaluation, consultation and optimisation work,
leading to an optimised WHELD champion intervention.
Aim and objectives
Work package 5 aimed to establish the effectiveness and cost-effectiveness of the optimised WHELD
programme and to determine which factors influence sustainability for use in UK care homes.
This was achieved through the following main objectives:
l A large RCT of the optimised intervention compared with usual care.
l An integrated cost-effectiveness analysis of the optimised intervention. To determine whether or
not the intervention is cost-effective is an important factor in whether or not commissioners and
private payers are likely to pay for the training.
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l A qualitative analysis of WHELD materials used by WHELD therapists and supervisors to determine
factors that are associated with successful implementation.
l A qualitative analysis with care home staff to determine the sustainability of the
WHELD programme.
Randomised controlled trial of the optimised WHELD programme in care
homes in the UK
The first phase of WP5 was a large-scale multicentre RCT of the optimised WHELD programme,
as described in a published output.180
Aim
The goal was to evaluate the impact of the WHELD programme on QoL, agitation, neuropsychiatric
symptoms, antipsychotic use, global deterioration, mood, unmet needs, mortality, quality of interactions,
pain and cost in comparison with treatment as usual (TAU).
Methods
Study design
This study was a 9-month, cluster, two-arm RCT conducted following Consolidated Standards of
Reporting Trials guidelines in 69 care homes in the UK. There were three recruiting hubs that were
based in north and south London and Buckinghamshire. Each cluster was randomised to receive either
the WHELD programme or TAU for 9 months. All residents with dementia (defined as a score of ≥ 1
on the CDR scale) were eligible. Rating assessments were conducted at two time points: baseline (prior
to randomisation) and after 9 months. This is described in a published output.181
Interventions
The WHELD programme focused on training in person-centred care for care staff, promoting tailored
person-centred activities and social interactions and the development of a system for triggering
appropriate review of antipsychotic medications by the prescribing physician. The intervention is
described in more detail in a published output.180
Outcome measures
The primary outcome was QoL, which was measured by the DEMQoL – proxy.182
The secondary outcome measures included:
l agitation – assessed using the CMAI158
l overall neuropsychiatric symptoms – assessed using the NPI-NH159,183
l global severity of dementia – assessed using the CDR154
l mood – assessed using the Cornell Scale for Depression in Dementia (CSSD)157
l antipsychotic use
l unmet needs – assessed using the CANE scale184
l quality of interactions – assessed using the Quality of Interactions Scale (QUIS)185
l pain – assessed using the Abbey Pain Scale186
l mortality
l cost.
Economic data for each individual in the study were collected using an adapted version of the CSRI.187,188
All assessments were undertaken based on informant interviews with members of care home staff that
were conducted by trained members of the WHELD research team.
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Randomisation and blinding
Nursing homes were allocated to receive either the WHELD programme or TAU using secure web access
[North Wales Organisation for Randomised Trials (NWORTH) Clinical Trials Unit at Bangor University].189
Sample size
Previous studies have indicated that intra-home correlation coefficients rarely exceed 0.05. Taking this
into account, a sample size of 640 participants at 9 months gives 90% power to a p-value of < 0.05 to
detect a standardised ES of 0.3 standard deviations (SDs), which is generally accepted as the lowest
threshold of a clinically meaningful benefit. The recruitment of a minimum of 840 participants allowed
for loss of 200 through mortality or withdrawal.
Data analysis
Outcome measures were assessed at baseline and at 9 months. The primary outcome measure (DEMQoL –
proxy) and the secondary outcome measures were analysed using the multilevel modelling approach to
analysis of covariance (ANCOVA), with the value at 9 months as the response. The baseline value was
the covariate.
Mortality and antipsychotic use were compared between treatment groups using relative risk with
95% CIs. QUIS used the care home-level data and was compared between treatment groups using
ANCOVA, but as a result of the smaller sample size did not use baseline covariates.
Cohen’s d is defined as the difference between two means divided by the SD of the data, that is the
difference in the means of WHELD and TAU divided by their pooled SD.
Cost analysis
Costs were derived from service use data collected over the 3-month period prior to the intervention
(baseline) and the 9 months of the intervention (follow-up) and consisted of three main cost categories:
intervention costs, accommodation charges, and health and social care costs. Data on each nursing home
resident’s use of health care (obtained from the CSRI) were multiplied by the appropriate unit costs
to calculate health and social care costs for each participant at each time point. The mean differences
in costs and 95% CIs were obtained by non-parametric bootstrapped regression (1000 repetitions),
modelling to account for non-normal distributions. A multilevel mixed model controlling for baseline
costs, site and age at entry into the study was used. The health economic analysis followed Consolidated
Health Economic Evaluation Reporting Standards (CHEERS) guidelines.
Results
Cohort characteristics
In total, 1006 participants were consented to the study, with 847 randomised to either TAU (n = 443)
or the WHELD programme (n = 404). Follow-up assessments were available for 553 participants (TAU,
n = 296; WHELD, n = 257), the majority of whom had moderately severe or severe dementia. Mortality
accounted for the majority of participants who did not complete follow-up. Anonymised data are
available in an online registry.180
Outcomes
The WHELD programme conferred a statistically significant 2.54-point (SEM 0.88-point) improvement in
QoL compared with TAU (95% CI 0.81 to 4.28 points, Cohen’s d ES of 0.24; p = 0.0042), as measured by
the DEMQoL – proxy over 9 months. The WHELD programme also conferred a statistically significant
4.27-point (z-score 2.68, mean difference –4.27 points, SEM 1.59 points, 95% CI –7.39 to –1.15 points,
Cohen’s d ES of 0.23; p = 0.0076) benefit on the CMAI compared with TAU with respect to agitation,
and conferred a statistically significant 4.55-point (z-score 3.52, mean difference –4.55 points, SEM 1.28
points, 95% CI –7.07 to –2.02 points, Cohen’s d ES of 0.30; p< 0.001) benefit on the total NPI-NH compared
with TAU. The main results are summarised in Table 1. The full results are described in a published output.180
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Prescriptions of antipsychotic medications were stable across the study in both treatment groups [change
in antipsychotic use: WHELD –0.1% (SEM 0.1%); TAU –0.2% (SEM 0.1%); p = 0.60]. There were no
statistically significant differences between the WHELD programme and TAU groups for change in global
severity of dementia, unmet needs, pain, mood or mortality. There was a statistically significant 19.7%
greater increase in the proportion of positive care interactions from baseline to 9 months in the WHELD
group than in the TAU group (SEM 8.94%, 95% CI 2.12% to 37.16%, Cohen’s d ES of 0.55; p = 0.03).
Adverse events
A total of 549 serious adverse events were recorded during the period of the trial. The events were
balanced between the two treatment groups, with no statistically significant differences.
Cost analysis
The direct cost of delivering the intervention compared with TAU was £8627 more per care home.
After adding the intervention to social and health-care costs, the cost per participant receiving the
WHELD programme was £4740 lower than the cost of those participants receiving usual care over the
9 months of the study (Table 2).
For the participants with a CMAI score of > 40, the relative treatment effect for health-related QoL
(as measured via the DEMQoL – proxy) increased at the 5% level (1.96, 95% CI 0.42 to 3.39) and the
benefit on the CMAI scale improved by more than 1 point compared with the base case (3.72; 95% CI
1.28 to 6.51). However, the difference in costs was around £400 less than in the ordinary least squares
model, with a part of the bootstrapped CI stretching to the positive part of the number line. The health
economic analysis is presented in more detail in a published output.190
Discussion
The WHELD programme conferred a statistically significant improvement in QoL over 9 months. There
was also a statistically significant benefit regarding agitation and overall neuropsychiatric symptoms,
and a significant increase in the proportion of positive care interactions between care staff and residents
with dementia. Importantly, the benefits were achieved in the context of cost saving with a model that
can readily be implemented in nursing homes.
Although comparable to atypical antipsychotics, the standardised ESs of benefit are modest in the
context of a clinical intervention. The benefits do, however, also include improvements in QoL, which
have not been shown with pharmacological interventions or other person-centred care interventions.
Although there is no established threshold for a clinically meaningful benefit in QoL or quality of care,
any statistically significant benefit is important given the lack of any benefit in previous RCTs. In addition,
the intervention was not just delivered to people with clinically significant neuropsychiatric symptoms,
but conferred benefit among the broader population of people with dementia living in care homes and
could, therefore, be considered as a health and well-being intervention rather than a clinical intervention
per se. Although the ES would be considered marginal in terms of a clinically significant benefit, we do
believe that the benefits to the broader population of people with dementia living in care homes make
this a meaningful benefit in the quality of care. The benefits were also smaller than hypothesised.
TABLE 1 Effect estimates of the WHELD programme in comparison with TAU on key outcome measures (multiple
imputation analysis)
Outcome measure Adjusted effecta p-value Mean difference (95% CI)
DEMQoL – proxy (n= 553) R= 0.12 0.0042 2.54 (0.81 to 4.28)
CMAI (n = 553) R= 0.11 0.0076 –4.27 (–7.23 to –1.15)
a Adjusted effect takes into account baseline value, age, sex, CDR, site and clustering within care homes.
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Agitation is a frequent and distressing symptom for people with dementia.191,192 The findings are
favourable when compared with trials of antipsychotic medications, which show only very modest
benefits over 12 weeks in the treatment of agitation in the context of significant harms.13,16 Our results
compare favourably with the small number of previous studies that focused on person-centred care,
in which benefits in agitation are inconsistent and none of which has reported benefits in QoL.28,30
In addition, this study shows cost advantages over usual care, which have not been demonstrated
with any previous drug or non-drug intervention.
Recent studies have begun to suggest that other pharmacological therapies, such as citalopram
(Cipramil, Lundbeck)193 and dextromethorphan (Neudexta, Avanir),194 may confer benefit for the
treatment of agitation; however, further studies are needed.
Elements of the WHELD programme, such as social interaction and pleasant events, have previously
been demonstrated to improve agitation in modest-sized RCTs.49,195 Incorporating these elements
within a coherent framework, such as WHELD, enables straightforward and affordable implementation.
In contrast to our previous factorial RCT of the WHELD programme, no significant reduction in
antipsychotics prescriptions was achieved. This is probably attributable to a combination of a small
number of baseline antipsychotic prescriptions and the more limited education programme for primary
care physicians. It should also be noted that the ICCs were higher than the 0.03 that was identified from
previous studies, which may have limited statistical power of the trial. Other limitations include the
challenges of measuring QoL for people with moderately severe and severe dementia and the potential
challenges of data analysis in the context of a frail group of individuals with high rates of mortality.
TABLE 2 Unadjusted mean costs and mean cost differences at baseline and over 9 months of the study (Great British
pounds, 2014–15)
Cost category
Cost (£), mean (SD) Intervention vs. TAU,
unadjusted mean cost (£)
difference (95% CI)Intervention TAU
The WHELD programme 2713 (121) 0 (–) 2713 (2701 to 2724)
Baseline (n = 887)
Accommodation charges 9480 (2010) 10,233 (3675) –753 (–1128 to –365)
Hospital 387 (1759) 407 (2413) –20 (283 to 242)
Primary care 96 (126) 98 (148) –2 (19 to 14)
Community health 23 (80) 19 (79) 4 (–7 to 14)
Emergency 12 (37) 9 (34) 3 (–1 to 7)
Total health and social care costs 9998 (2601) 10,766 (4396) –768 (–1249 to –338)
9 months’ follow-up (n = 553)
Accommodation charges 28,606 (10,863) 33,005 (12,428) –4399 (–5725 to –2898)
Hospital 269 (1166) 262 (1267) 7 (–183 to 188)
Primary care 700 (294) 1,020 (301) –320 (–364 to –277)
Community health 78 (260) 70 (206) 8 (–23 to 44)
Emergency 49 (133) 85 (244) –36 (–68 to –10)
Total health and social care costs 29,702 (8774) 34,442 (11,106) –4740 (–6129 to –3156)
Reproduced from Ballard et al.180 This is an Open Access article distributed in accordance with the terms of the Creative
Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/. The table
includes minor additions and formatting changes to the original table.
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Pain was a prespecified secondary outcome for the WP5 WHELD RCT. Given that several members of
our research group were particularly interested in pain in people with dementia, which we consider to
be a key factor for health and well-being, we made these data available for a more detailed evaluation.
This was an added value to the outputs from the programme and led to a secondary paper that focused
on pain experienced by people with dementia. The baseline prevalence of pain was 35.3% among residents
with dementia. Pain severity was significantly correlated with dementia severity, neuropsychiatric
symptoms, depression, agitation and QoL at baseline and at 9 months. Regular treatment with analgesics
was associated with reduced pain severity. Pain was significantly associated with more antipsychotic
prescriptions and with all-cause mortality during follow-up (OR 1.48, 95% CI 1.18 to 1.85). See the
published output for the full paper.196
Field testing and implementation of the WHELD programme in care homes
in the UK
Aim and objectives
This evaluation gathered information on the experiences of the WHELD therapists and supervisors at
the end of the intervention period, and from care home staff after a period of 9–12 months following
study completion.
Methods
Focus group discussions were conducted with the 12 members of the therapy team who had delivered
or supported the intervention in the WP5 RCT to explore the therapist and supervisor experiences of
delivering the intervention. The detailed findings are reported in a published output.197
Results
The WHELD therapist focus group discussions
Feedback on therapist training and supervision
The therapists reported that they had received comprehensive training and that the content of the
interventions and the expectations of how they would be delivered was clear.
The participants identified areas that they felt required particular support. This included ensuring
that they had the skills that were required to train dementia champions. The participants particularly
supported the use of experiential exercises for successful learning. Therapists felt that the development
of their coaching skills during supervision was particularly valuable, as well as ensuring that there was
promotion of a multicultural attitude and awareness of differences in language and needs among staff.
The importance of ongoing supervision within the homes and for the WHELD therapists themselves
was also seen as an essential feature.
Developing relationships with care homes and staff
Therapists strongly articulated the importance of establishing a good working relationship with care
home managers and staff early in the study. This required a genuine interest in the care team as
individuals to build relationships and support the dementia champions. All therapists acknowledged that
a flexible approach was imperative. Some therapists felt that, on occasion, they were adding pressures on
staff, who were trying to find a balance between fidelity to the intervention and other work duties.
Optimising success of the champion role
There was a strong consensus for advocating self-selection of dementia champions rather than nominating
people for the role. Having multiple champions in each home was also strongly supported, as this provided
peer support and built complementary skills. Buy-in from the home manager was a critical driver for
success, as it enabled staff to dedicate time to the role. The therapists perceived that many dementia
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champions enjoyed the role and felt empowered in promoting activities and ideas with residents. For
many dementia champions, reflecting on their practice was a new and appreciated way of working.
Therapists spoke positively about the effect of the WHELD programme on care home residents. They
spoke with enthusiasm about the many individualised activities that care home staff enabled and how
staff became creative in responding to people with diverse needs.
Focus group discussions with care home staff
Care homes receiving the WHELD programme were invited to take part in focus groups 9–12 months
after the intervention had concluded. The results are reported in detail in a published output.198
Demographics
In total, 47 care home staff participated in the focus groups. Almost half of the participants were
carers or senior carers, three were nurses (6%), six were activity co-ordinators (13%), three were
managers (6%), six were assistant managers (13%) and six were traditionally non-direct care roles
(13%). A total of 32% of focus group participants were WHELD dementia champions during WP5.
The remaining participants started work in the home after the intervention had finished.
Value of the WHELD programme
The first theme that emerged related to staff recognising the value of the research for different groups of
people. They described benefits in the way that they recognised the individual and interpersonal needs of
residents and acknowledged that some of the methods allowed them to get to know residents better,
which led to positive responses from the residents that were rewarding for staff. Staff also saw value for
themselves in forming relationships within the team and enhancing their ability to provide care. During
the study, some homes had adapted their organisational routines and found this helpful in developing a
team approach to sharing person-centred care principles with the wider staff group. Many homes felt that
participating in the WHELD programme had also changed their perspective on working with families.
Skills development in care staff: ‘being well practised’
The second theme related to the skills staff felt that they developed. All care homes felt that the person-
centred philosophy was a feature that had endured following the research. A notable element in achieving
this was the development of empathy and being able to identify more closely with residents. Experiential
learning exercises, which were run by dementia champions with their colleagues, were particularly helpful.
The WHELD programme also helped care home staff to develop new communication skills and improve
their ability to tailor their approach to individuals. The sustained change in perception that activities could
be carried out at ‘any time’ and could be incorporated into physical care tasks through the use of
conversations and short individual activities was particularly beneficial.
Sustainable practice: ‘taking ownership’
The third theme that emerged was being able to adopt the ‘WHELD’ approach as the ‘home’s own’.
Where there was a strong local leadership from managers and peers to develop creative ways of
working with residents, the care homes found ways to continue with the approach and ensure that the
underlying philosophy and valued practice was not lost.
Perspective on research involvement
The staff generally held a positive view of research and a sense of pride at having contributed to a
major study.
Discussion
Discussion with care home staff represented a unique opportunity to explore their perceptions of the
long-term impacts of the WHELD programme and the factors influencing its sustainability. The focus
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group discussions highlighted that the ethos of person-centred care and associated approaches can be
embedded and that a number of the WHELD materials continue to be used after study involvement
has ceased.
Concluding remarks from work package 5
Work package 5 successfully delivered a robust and rigorous clinical evaluation of the optimised
WHELD programme utilising a champion’s model. Significant benefits were seen in the treatment of
agitation, overall scores of neuropsychiatric symptoms and health-related QoL in individuals with
agitation compared with TAU.
There are also economic benefits from a low-resource multicomponent intervention that is aimed at
people with dementia living in a care home setting.
Feedback from therapists and staff involved in the trial also confirmed a positive and empowering
experience.
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Work package 6: dissemination of the
study outcomes and impacts
Abstract
Objectives: WP6 sought to effectively disseminate the findings of the programme to impact on
practice and maximise the output of the research.
Methods: A dedicated dissemination phase involved a series of tailored activities to maximise the
impact of the WHELD programme. Work included academic publication and presentations, outreach to
GPs, updating of national best practice guidelines and additional events for care homes.
Results: The dissemination activities were successfully completed. Key activities included regional
workshops for GPs, which received excellent feedback and response, and the creation of an e-learning
module for GPs with the British Medical Journal learning portal. The national guidelines on BPSD
management were updated and endorsed by NHS England. Additional events and workshops were held
with care home staff, and investigators presented the findings at numerous national and international
conferences. All findings were prepared for publication in peer-reviewed journals.
Conclusions: WP6 constituted an integrated and broad approach to ensure that the outputs of the
WHELD programme were effectively communicated in a targeted manner. WP6 exemplifies the
success of the WHELD programme and highlights the importance of the key findings from the clinical
evaluations that were conducted throughout the study. Involvement of key health-care professionals,
particularly GPs and care home staff, was purposely selected to ensure that the learning from the
programme informs future practice in a meaningful way.
Background and rationale
The WHELD programme consisted of a series of high-quality research elements that sought to
understand the UK care home landscape, develop and optimise a complex care intervention, evaluate
it in a real-world environment and fully understand its implications for care home residents and
staff. Ultimately, the aim of this programme was to improve the care that is provided to people with
dementia, with a focus on improving management of BPSD, increasing QoL and promoting the
judicious use of antipsychotic medications.
Dissemination activity is an integral aspect of a successful research programme and an essential step in
ensuring that research informs improvements to clinical and care practice. There was, therefore, a need
to dedicate time and resources to the final adaptations of the intervention, inform peripheral resources
to support ongoing implementation and move towards the roll-out of WHELD as an intervention.
Aim and objectives
Work package 6 aimed to maximise the impact and success of the WHELD programme through a
dedicated dissemination package. This was achieved through the following specific objectives:
l academic publication of the findings collated throughout the WHELD programme
l population of a dedicated website to promote the WHELD outcomes
l delivery of workshops to GPs across the UK to disseminate the findings
l updating of the national BPSD management guidance resource, in partnership with NHS England
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l creating an e-learning module for GPs in partnership with the British Medical Journal
l seeking additional opportunities for presentations and workshops to target audiences
l disseminating findings to care home audiences through events and tailored communications
l seeking opportunities for further funding to promote implementation of the WHELD programme.
Dissemination activity
Publications
The outputs from each WP in the WHELD programme have been successfully published, with some
additional publications in writing or in press at the time of publication of the final report (see
Publications).
The WHELD programme website
A succinct online presence was created for the WHELD programme to provide information about the
study and its impacts. The site is hosted by Oxford Health NHS Foundation Trust at www.oxfordhealth.
nhs.uk/research/making-a-difference/improving-wellbeing-and-health-for-people-with-dementia-wheld/
(accessed 4 November 2019).
The website does not aim to provide detailed information about the intervention. Instead, it is tailored
to an online audience, providing snapshots of its impacts and YouTube (YouTube, LLC, San Bruno, CA,
USA) video footage of care home staff describing their experience of the study. There are also plans to
produce additional pieces of video footage in the future as part of an ongoing resource to support
training.
General practitioner learning workshops: optimising the use of antipsychotic medication and
non-pharmacological treatment for people with dementia
A major dissemination activity for WP6 was a series of GP workshops that ran across the UK from
November 2015 to January 2016. The GP training resources used in the factorial study in WP3 were
accredited and used as the basis for these events. The 4-hour workshops were held in York, Exeter,
Bicester (Oxfordshire), Manchester and London. In addition to information provision, workshops
were delivered with additional time for GPs to explore how they could implement best practice in
antipsychotic prescribing and support care home staff to adopt non-pharmacological approaches
in response to BPSD. All the workshops were facilitated by a core group from the WHELD team,
with other members of the project team and local figureheads supporting individual workshops in
each locality.
Feedback from the 118 attendees at the GP workshops was overwhelmingly positive, with all members
rating their learning as ‘very effective’ or ‘effective’, and stating that the event had met their learning
objectives. Testimonial statements from attendees included the following:
I was surprised to discover that antipsychotics are not very effective and glad to discover that social
interaction has evidence to support its recommendation.
I obtained more information on antipsychotic medication use in people with dementia.
Understood the risks around prescribing antipsychotic medication. Makes complete sense to use a
person-centred approach.
Became aware of non-pharmacological methods of managing behavioural problems in dementia.
Excellent, very interesting and relevant afternoon.
Definitely think harder about risks and harm of prescribing drugs and benefits of not.
WORK PACKAGE 6
NIHR Journals Library www.journalslibrary.nihr.ac.uk
48
This programme has now been accredited by the Royal College of General Practitioners for further
training workshops.
Creation of a British Medical Journal e-learning module for general practitioners
Outreach to primary care and eliciting change in these settings is known to be challenging as a result
of the competing priorities that GPs experience in their role. An online resource for GPs was also
created to increase the reach of the learning for GPs, inform judicious antipsychotic prescription and
promote the use of non-drug treatment approaches. An e-learning module was created in partnership
with the British Medical Journal that collated the key clinical messages arising from the WHELD
programme.
The e-learning module was created through the following steps:
1. An initial discussion between British Medical Journal authors and investigators (AC, CB and JF) to
establish the format and timelines for delivery.
2. The creation of 12 learning objectives. Objectives were designed to have a practical focus with
relevance to commonly encountered situations in clinical practice.
3. Joint working between the British Medical Journal writing team and the investigators to create
12 scenarios, which were based on the learning objectives. Each scenario included four possible
outcomes, with one correct answer, two partially correct and one incorrect answer. Each answer
given was accompanied by further information to support understanding.
4. The final version of the module was created by the British Medical Journal and approved by the
investigator team (CB, JF and AC).
The WHELD e-learning module has now been launched as part of the British Medical Journal portfolio
of online health-care education materials, British Medical Journal Learning. Sign Up Form – Dementia
Assessment Module.
Update of best practice guidance for management of behavioural and psychological
symptoms of dementia
A core element of the antipsychotic review component of the WHELD programme was derived from
an existing best practice guide published by the Department of Health and Social Care and the
Alzheimer’s Society in 2012. Authorship of the original version of the guide involved several of
the WHELD programme investigators, which has become widely used in the UK and worldwide.
The outcomes of the WHELD programme, in addition to newly published evidence from related
studies,21–23,25,27,149 resulted in the existing guide becoming outdated.
A key dissemination activity was, therefore, to produce an updated version of the best practice guide
as a means of promoting evidence-based practice in addition to disseminating the outcomes of the
WHELD programme. This process involved the following steps:
1. review of the existing manual by the three leading authors (CB, AC and Professor Alistair Burns)
2. involvement in a Delphi consensus meeting led by the International Psychogeriatrics Association in
2015, which discussed recent evidence pertaining to BPSD management and antipsychotic use
3. collation of the relevant WHELD outcomes with the Delphi outcomes
4. creation of detailed changes to the content and format of the best practice guide
5. liaison with a professional designer to adapt the guide
6. approval of the updated guide by all of the related authors.
The guide is endorsed by NHS England (primary endorser), the Alzheimer’s Society and the Royal
Colleges and is available online (URL: http://medicine.exeter.ac.uk/apex/research/#tab2; accessed
27 May 2020).
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Additional outreach activities
The WHELD investigator team has also contributed to a number of events, presentations and publicity
opportunities as part of WP6 and developed some further research. These are detailed in Appendix 1.
Concluding remarks from work package 6
Work package 6 constituted an integrated and broad approach to ensure that the outputs of the
WHELD programme were effectively communicated in a targeted manner. WP6 exemplifies the
success of the WHELD programme and highlights the importance of the key findings from the clinical
evaluations conducted throughout the study.
Furthermore, the involvement of key health-care professionals, particularly GPs and care home staff,
was purposely selected to ensure that the learning from the programme informs future practice in a
meaningful way.
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Overall summary and discussion
Patient and public involvement in the WHELD programme: discussion and
reflections on the programme by our patient and public involvement
co-investigator
Contributed by Barbara Woodward-Carlton (lay co-investigator)
I was very pleased to be invited to be part of the WHELD project funded by NIHR some 6 years ago.
I can remember saying to Clive Ballard ‘do you really think I can do this?’. After this length of time I can
say, sincerely, it has been gratifying to have an involvement in this research. I had worked with the lead
researchers as a Research Network Volunteer, Alzheimer’s Society, on the Focused Intervention for
Training of Staff project which had demonstrated that, beyond doubt, quality of life could be greatly
improved for people with dementia in care homes by implementing the evidenced based findings of
that project.
The WHELD research which followed on from that project has made a huge difference to the lives of
those with dementia in care homes. The WHELD Therapist and Dementia Champions Manuals are models
of thoroughness based as they are on person-centred care enabling successful psychosocial interventions
in care homes. The training for the therapists and other members of staff enables knowledge to be
translated into practice and the enhancement of skills.
To deliver planned personalised interaction to residents involving staff, families, and volunteers
necessitates training. The resources provided are truly comprehensive and if properly used in care homes
transform the lives of both those with dementia and those who care for them and so give a greatly
enhanced quality of life to both groups.
I am totally convinced of the value of this research, the results are simply stunning. I hope it can be
successfully implemented in care homes across the UK and even beyond. As someone who has been
involved in PPI for many years now, knowing that such interventions can make a huge difference to
lives of those with dementia, it is my fervent hope that these findings will be adopted throughout the
care system. It has been my pleasure to have had an involvement with such a group of talented, caring
researchers who are so committed to making life better for those with dementia. It would be such a waste
of money, expertise and time if such planned personalised interactions did not become compulsory in all
care homes.
Barbara Woodward-Carlton, lay co-investigator
Additional PPI is summarised in Table 3, reported in line with the Guidance for Reporting Involvement
of Patients and the Public 2 (GRIPP2) framework.199
Investigator team discussion and reflections on the WHELD programme
The WHELD programme built on a series of systematic reviews to design and optimise a person-centred
care training package by augmenting person-centred care with personalised pleasant activities/social
interaction, exercise and antipsychotic review. This was evaluated in a factorial RCT that demonstrated
tangible added benefits, including improvements in QoL and reduced mortality as well as a reduction
in antipsychotic use. Further optimisation of the intervention developed a training approach that used
a champion model to make the programme more pragmatic: an essential component for successful
implementation. The definitive RCT of the WHELD champion intervention conducted in WP5 showed
DOI: 10.3310/pgfar08060 Programme Grants for Applied Research 2020 Vol. 8 No. 6
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Ballard et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
51
significant benefits in QoL and neuropsychiatric symptoms (including agitation) for people with dementia at
a lower cost than usual care. This provides an evidence-based platform to enable effective implementation
in care home settings for people with dementia.
Although the programme had a number of methodological strengths, there were also limitations.
The qualitative work undertaken to inform the optimisation of the intervention was focused largely
on the participating staff who were responsible for delivering the intervention, but we recognise that
residents with dementia who received the intervention delivered by the staff were not included in
the qualitative studies and could provide a valuable perspective. In designing the study, we carefully
considered the challenges of measuring QoL in people with moderate to severe dementia and,
therefore, relied predominantly on a proxy measure. In addition, we opted for a TAU control in WP5
because of the scale of the study (i.e. 69 care homes), but this may have inflated the magnitude of
observed benefits.
TABLE 3 The WHELD programme PPI reporting (reported according to the GRIPP2 framework)
Section and topic Item
Aim The aim was to integrate PPI in a meaningful way in the WHELD programme, focusing on the
views, experiences and perspectives of people affected by dementia and people who support
them in care homes
Methods PPI in the WHELD study involved:
l a lay representative (Barbara Woodward-Carlton) as a full member of the PMG
l lay representation in the TDG, who led the design and development of the
WHELD programme
l the TDG and focus groups with care staff in WP4 to discuss experience of research and to
contribute to the development of the optimised WHELD programme
l lay representation in specialist groups involved in the consultation phase in WP4, which
optimised the WHELD programme
l partnership with the Alzheimer’s Society to inform PPI and dissemination strategies
Study results Outputs relating to PPI in the WHELD programme were:
l co-investigator Barbara Woodward-Carlton was fully involved and embedded in the WHELD
management process and contributed to the management, development and intervention
discussions and dissemination
l sharing events involving care home staff to highlight study achievements held after WPs 3
and 5
l a care home manager participated in the ENRICH project to provide lay information for other
care homes considering research involvement (URL: https://enrich.nihr.ac.uk/resources/;
accessed 5 November 2019)





The PPI activity involved some family carers and predominantly people working in care homes,
who contributed their perspectives on the overall research process and advice on the
development of the research intervention. These participants had the most relevant experience
related to delivering the intervention and so their views were prioritised. Their contribution
shaped the overall project development, shared between participating centres and has also been
documented through ENRICH to enhance learning more widely
Reflections/critical
perspective
Stakeholder views were sought for each WP and dissemination of the project and have
contributed to the overall results
Advice was not sought directly from people with dementia living in care homes as part of the process
and could have been a valuable addition to the PPI process. Many care home residents have advanced
communication difficulties and engaging them in the process would require creative and adapted
strategies. Our reflections on this have led to the development of a project to improve communication
with people with these needs, which is being led by the University of Exeter
OVERALL SUMMARY AND DISCUSSION
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The intervention in WP5 was optimised not just for efficacy, but to also to design an intervention
that was more suitable for practical implementation in real-world settings. However, as part of the
adaptation of the intervention there was a less proactive approach to GP education as part of
antipsychotic review and the modified WHELD programme did not achieve an overall reduction in
antipsychotic use in this RCT. The GP intervention has been developed as a British Medical Journal
educational module and in practice it should, therefore, be possible to implement the WHELD
programme directly in care homes and promote the GP educational component in parallel.
A key question is whether or not the benefits are meaningful. The standardised ESs of benefit for the
WHELD programme were small in the context of a clinical intervention (Cohen’s d standardised ESs
0.23–0.3). However, the benefits included improvements in QoL, which have not been demonstrated
with other pharmacological or non-pharmacological treatments. The benefit in QoL was modest but is
important given the absence of any benefit in previous studies. The findings are particularly favourable
when compared with those of trials of antipsychotic medications that show only modest benefits in
treating agitation over 12 weeks and with the potential of significant harms.
Discussion of implications for practice
First, with regard to antipsychotic use, the clinical trials in the programme provide evidence that advocates
the continued judicious prescribing of antipsychotics that follows the changing landscape of their use in
the UK and worldwide. Given the findings related to antipsychotic review, prescribers should balance the
potential impacts of antipsychotic withdrawal and carefully balance the harm-to-benefit ratio associated
with antipsychotics.
Second, the WHELD programme has clearly demonstrated the value of social interaction and
individualised pleasant activities in the treatment and care of people with dementia. Clinicians and care
staff should consider these approaches as part of usual care.
Furthermore, the qualitative work conducted in this programme has identified opportunities and
challenges in implementation of psychosocial approaches in care homes.
Recommendations for future research
The WHELD investigator team would like to make recommendations for future research in this field.
First, there is a need to examine the sustainability of the WHELD programme in care homes. The
programme has demonstrated effectiveness over 9 months and this raises the question of whether or
not this impact would be translated to longer-term effects for residents.
Future research might also examine cost-effective models of delivery to achieve sustained benefit.
A pilot is under way to develop an e-learning version of the WHELD programme and it will be
important to evaluate the effectiveness of this approach for care staff and its impact on residents.
An interesting secondary outcome from the RCT in WP5 was the significant impact of the intervention
on pain in people who had significant pain at baseline. Pain is a major health concern in people with
dementia and is a common underlying factor in BPSD. Therefore, it will be interesting to consider
the effectiveness of training and tailored non-drug interventions on this key clinical factor.
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Clive Ballard (https://orcid.org/0000-0003-0022-5632) (Professor of Age-Related Diseases at the
University of Exeter) was the chief investigator for this programme and was a member of the TDG
and PMG.
Martin Orrell (https://orcid.org/0000-0002-1169-3530) (Director of the Institute of Mental Health at
the University of Nottingham) co-led WP2 and was a centre lead for the RCT in WP5. He was a
member of the TDG and PMG.
Esme Moniz-Cook (https://orcid.org/0000-0002-7232-4632) (Professor of Clinical Psychology at the
University of Hull) co-led WP2 and the TDG, and was centre lead for the RCT in WP5. She was a
member of the PMG.
Robert Woods (https://orcid.org/0000-0002-6781-651X) (Director of Dementia Service Development
Centre) chaired the PMG.
Rhiannon Whitaker (https://orcid.org/0000-0003-4305-3236) (Senior Statistician at Bangor University
and is CEO of Whitaker Research Ltd) led the statistics and statistical design of the programme and
was a member of the PMG.
Anne Corbett (https://orcid.org/0000-0003-2015-0316) (Senior Lecturer in Dementia Research at the
University of Exeter) led WP6.
Dag Aarsland (https://orcid.org/0000-0001-6314-216X) (Chairperson of Old Age Psychiatry at King’s
College London) led work in WP1 and was a member of the TDG and PMG.
Joanna Murray (https://orcid.org/0000-0002-7348-7505) (Senior Lecturer in Qualitative Research at
King’s College London) led the qualitative research analysis in WP3 and was a member of the PMG.
Vanessa Lawrence (https://orcid.org/0000-0001-7852-2018) (Lecturer in Qualitative Research at
King’s College London) led the qualitative research work in WP2 and co-led WP3.
Ingelin Testad (https://orcid.org/0000-0002-0534-6575) [Director of SESAM (Centre for Age-related
Medicine) at Stavanger University and Professor of Nursing at the University of Exeter] led recruitment
to the RCTs in WP3 and WP5.
Martin Knapp (https://orcid.org/0000-0003-1427-0215) (Professor of Social Policy at the London
School of Economics) led the health economics in WP3 and WP4 and was a member of the PMG.
Renee Romeo (https://orcid.org/0000-0003-3871-9697) (Senior Lecturer in Health Economics at
King’s College London) managed the health economics analyses for data arising from WP3 and WP5.
Darshan Zala (https://orcid.org/0000-0001-5020-2354) (Research Associate at King’s College London)
supported health economics data analysis from WP3 and WP5.
Jane Stafford (https://orcid.org/0000-0002-4964-075X) (Programme Manager at Oxford Health NHS
Foundation Trust) was the programme manager for WHELD.
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Zoe Hoare (https://orcid.org/0000-0003-1803-5482) is a Senior Statistician at NWORTH in the
University of Bangor. She supported statistical analysis for WP5.
Lucy Garrod (https://orcid.org/0000-0003-4378-1372) (Research Therapist at Oxford Health NHS
Foundation Trust) was a WHELD therapist in WP3 and therapy supervisor in WP5 and contributed to
the qualitative evaluation in WP5.
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University) performed statistical analysis for WPs 3 and 5.
Eddie McLaughlin (Director of Adult Mental Health Services at Oxford Health NHS Foundation Trust)
was the NHS manager for the programme.
Barbara Woodward-Carlton (Research Network Volunteer at Alzheimer’s Society and a former carer
of a person with dementia) provided a lay perspective throughout the programme.
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London) contributed to statistical analysis and interpretation and co-writing of WP5.
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management and was a member of the TDG and PMG.
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Data-sharing statement
All data requests should be submitted to the corresponding author for consideration. Access to
available anonymised data may be granted following review and appropriate agreements being in place.
Data from the RCT described in WP5 is in the Dryad repository (URL: https://datadryad.org/resource/
doi:10.5061/dryad.75373; accessed 1 November 2019).
The authors will be happy to discuss potential collaborations regarding other data and will make
anonymised data available on that basis.
Patient data
This work uses data provided by patients and collected by the NHS as part of their care and support.
Using patient data is vital to improve health and care for everyone. There is huge potential to make
better use of information from people’s patient records, to understand more about disease, develop
new treatments, monitor safety, and plan NHS services. Patient data should be kept safe and secure,
to protect everyone’s privacy, and it’s important that there are safeguards to make sure that it
is stored and used responsibly. Everyone should be able to find out about how patient data
are used. #datasaveslives You can find out more about the background to this citation here:
https://understandingpatientdata.org.uk/data-citation.
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Appendix 1 Working papers in respect of
work package 3
Agreed work plan
WHELD WP3 work plan 
SAP for WP3 has currently not been executed in full. Some of this analysis will inform the analysis of WP5. 
Tasks 
1. YS to gather all reports given to Rhiannon  ⃝ 
2. YS to do demographics/descripve analysis  ⃝  
a. This is to include an assessment of those who did not complete FU.  ⃝ 
With agreement from the PMG we will analyse as an independent data set (this requires as a minimum to take 
clustering into account in the models). 
Care home 3006 will be analysed as it was allocated to PCC intervenon group, but not to its originally 
allocated intervenons, i.e. all the other three intervenons in addion to PCC. The analysis will be run 
including and excluding this care home to noonally describe the effect. 
Drug data 
Antipsychotics 
Binary data at baseline was provided by the trial team.  
Follow up data for inial analyses completed using binary data constructed by YS using drug assessment date. 
We now understand that this should have been the main assessment date.  
A reasonable assumpon to make at this point would be to assume that this binary data has been constructed 
correctly.  
It has now been decided that the variable has been constructed correctly. Drug assessment date and main 
assessment date may be up to 1 month apart. This is to be considered as one me point. 
YS to provide the cases where this window is exceeded to allow a descripon of the distribuon and and assess 
on a case by case basis what to do for each of these ⃝  
The information has now been clarified for WP5. 
Psychotropics 
Binary data will be constructed at baseline and follow up using the same criteria as for anpsychotics.  ⃝  
Essenally, we will use the assumpon “no stop date implies sll on drug” to construct the binary data on 
condion that the paent has used the drug(s) in the last 12 months. 
A=Assessment date, DS =drug start date, DE=drug end date, (when construcng this variable ignore drug 
assessment date). 
DS>DE>A Assign 0 not on drug 
DS>A>DE Assign 1 on drug 
A>DS>DE Assign 0 
DS>A no DE Assign 1 on drug 
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A with NO DS or DE assume if drug recorded then assign 1 on drug . If this is a large proporon of cases we may 
need to check this with a sensivity analysis. 
Deaths 
A complete case analysis will be carried out first, which means all deaths will be excluded from the analysis 
inially because they have not provided any data for outcome measures at follow up stage. 
In the second step, analyses will be carried out to impute deaths as “best” and “worst” scenarios, where 
appropriate, to see how the results for complete case analyses will change. 
Do a sensivity analysis with the Y:- 
1. Assign Y all 0 no drug ⃝  
2. Assign Y all 1 on drug ⃝  
3. Randomly assign 0/1’s in proporon with what is seen in the data set. This may be sensible to do on a 
MI level.  ⃝ 
1 and 2 will give the extremes of the assumpon and 3 will give a feeling of what was likely to have happened. 
For connuous variables mulple imputaon in the usual way will be included in all analysis. This is for both the 
withdrawals and the deaths. 
Finally the analysis plan should be run including the clustering ⃝  
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Analysis plan
WHELD WP3 Statistical Analysis Plan
An Opmized Person Centred Intervenon to Improve Mental Health and 
Reduce Anpsychocs amongst People with Demena in Care Homes
Version 1  12/9/12 
CO- SPONSORS: Oxford Health NHS Foundaon Trust & King’s College, London
FUNDERS: NIHR Programme Grants for Applied Research 
STUDY COORDINATION CENTRE:  Oxford Health NHS Foundaon Trust 
COREC reference: 11/SC/0066
DATA MANAGEMENT CENTRE: NWORTH - Bangor’s Clinical Trials Unit
Statiscal Analysis Plan Authorship 
Rhiannon Whitaker Methodological
PI/Stascian
Yongzhong Sun Trial Analyst 
Clive Ballard Chief Invesgator 
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 1 STUDY DESIGN 
The study design is a cluster randomised, 2x2x2 factorial design with 2 replicaons, pilot study in 16 
care homes.  It is esmated that each cluster will include a minimum of 12 parcipants (depending upon 
size of the care home, the number of people with demena and the number consenng). 
Each cluster will receive a randomly allocated intervenon for a minimum of 9 months. 
2 DATA MANAGEMENT AND ANALYSIS 
It is planned that anonymous data and all appropriate documentaon will be kept securely for a period of 7 
years following the compleon of the trial, subject to discussion with relevant Ethics Commiees. 
 
Quantave data management 
Administrave databases will be held at the study centre.  All parcipants and care homes will be identified by 
a unique study number; this number will be used to tag all research data sent outside the study centre, for 
example to NWORTH.  Quantave research data will be entered via a web interface to the MACROTM research 
databases held at NWORTH.  Primary data management will be conducted by the research team in the study 
centre, and the secondary cleaning and preparaon of the data for analysis will be conducted by NWORTH.   
 
2.2   Missing data and imputation strategies 
There will be four types of missing data for a parcipant in the dataset:  
 Baseline demographic details 
 Missing items within a quesonnaire  
 Missing outcome measures at follow up 
 Complete missing data at follow up (usually arising from parcipant death). 
Key demographic variables will be obtained directly from care homes where possible. Where 
demographics are described, missing data will be noted.  In order to maintain power, if a key covariate 
is missing, modal group substuon will be used to facilitate the analysis.  
For items missing within a quesonnaire: 
 First the published rules for dealing with missing items for the relevant measure will be used 
where appropriate.   
 Further missing items will be replaced with the mean score (mean value substuon MVS) of 
the remaining items in the quesonnaire as long as the number of missing items does not 
exceed 10% of the total number of items in the quesonnaire.   
 If there are more than 10% missing items in the quesonnaire the outcome measure will not 
be calculated at that me point. 
 
Complete case data will be defined as the data for parcipants whose relevant outcome measures at 
both baseline and follow up (at 9 months) are available aer implemenng the “10% rule”.  
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Full data set:  Once the missing item rules have been applied we will make a full assessment of the 
remaining missing data and any consequenal systemac biases which may occur by only analysing 
complete case data.  Then we will design and test potenal imputation strategies we may employ in 
WP5. These imputaon strategies will be simple, clear and meaningful, to provide useful 
interpretaons.  We will run a series of sensivity analyses (using the analysis plan described below) 
to test the imputaon strategies both for defining the bounds of the analysis (extreme case scenarios) 
and for the a priori design of the imputaon strategy for WP5. Parcular aenon will be made to 
establishing a best pracce soluon for dealing with the missing endpoints due to death.  
3 STATISTICAL ANALYSIS 
Outcome measures for pilot evaluaon will be assessed at baseline and 9 months and are listed in 
Appendix 1.  Each measure will be calculated as given in the relevant reference papers for that measure 
where appropriate although some flexibility needs to be maintained.  
3.1  Descriptive analysis 
 The trial parcipant and care home flow will be reported to CONSORT standards. Descripve 
stascs for three different intervenons AR (anpsychoc review), SI (social intervenon and 
pleasant acvies) and Ex (exercise) in characteriscs at both the individual paent and care home 
levels will be tabulated. Graphical techniques will be used where necessary. Any paerns of missing 
data will be described. The CONSORT diagram informaon will be assessed to idenfy potenal 
differences in dropout rates and other data quality issues in order to inform the design of WP5 
3.2  Modeling strategy  
The covariates with major baseline differences will be detected and they are potenal confounders 
and will be adjusted for in the corresponding ANCOVAs  in the following steps. 
The study hypotheses will be tested with standard mulple linear regression models for connuous 
outcome measures and with standard logisc regression models for binary outcome measures, 
followed by specifying robust standard errors to assess the likely effect of the clustering on standard 
errors to allow for the clustering within care homes.  To address the problem of possible discrepancy  
resulng from the above two procedures, suitable summary measures for each cluster may be 
calculated and these summary measures then will be analysed using standard linear regressions, to 
provide further assurance regarding the appropriate conclusions. 
This is a pilot study therefore, for simplicity, we will analyse data only for those individuals with 
complete data because we only have two measurement occasions.  We will then perform a series of 
sensivity analyses based on some well-considered imputaon strategies to assess the robustness of 
our main analysis results based on the complete data. 
The strategy for linear and logisc regression modelling work is based on the individual post-
treatment measurements at 9 months (as outcome measures) and is illustrated in figure 1. 
 
Stage 1.  We consider the three different interventions AR, SI and Ex separately in three regression 
models; this gives us the maximum power to obtain an inial idea about the crude treatment effect: 
how a parcular intervenon is effecve in achieving a desired treatment result for a specific 
outcome measure by comparing the group of all individuals on the treatment with that not on the 
treatment. In this way, the full potenal of a factorial design may be ulised.  In parcular, this 
modelling assumes no interacons between treatments. 
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Stage 2:  We investigate whether the treatment effect of one intervenon is accounted for by the 
other two intervenons.  The presence or absence of the three intervenons will be simultaneously 
entered into the model to see which effects remain significant.  If an intervenon is found to be non-
significant in relaon to a specific outcome, the binary exposure may be excluded from the model. 
This may imply that this intervenon has lile or no effect on the outcome when taking the other 
intervenons into account. 
 




Stage 3: We will include baseline outcome as a covariate at this stage to provide the best precision of 
treatment comparisons between each of the three intervenons and person centred care (PCC) at the 
end of treatment.  Then the possible confounders detected from the descripve analysis will be 
adjusted for in a forward stepwise process.  The aim is to achieve the most accurate and precise 
esmates of the treatment effect. 
Stage 4: Two-way interacon effects between treatments and between treatments and other 
baseline covariates may be examined at this stage, focusing on those that are of most interest to us. 
In parcular, for interacons between two intervenons, we will adopt a p-value of 10% as the 
threshold for significance to reflect the exploratory nature of this invesgaon and to ensure that we 
idenfy any promising effects. These interacon terms will be added into the model one by one, to 
ensure the maximum power to detect them. They have been le to the last step, after allowing for all 
other possible linear adjustments to explain the model. The results based on this model may be used 
to describe the addional benefits conferred by the 3 key intervenons compared with PCC.  
Stage 1
• Three pairwise comparisons (AR vs not AS, SI vs not SI and EX vs not Ex)
• Assume no interacons.
Stage 2
• Test if one intervenon is confounded by the presence of the others
Stage 3
• Adjust the model from stage 1 by adjusting for baseline.
• Include cofactors and covariates in a forward stepping process 
• Aim is to achieve most accurate and precise esmates of treatment effects
Stage 4
• To examine interacons between treatments and between treatments and  
other baseline covariates
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If any interacon effects between treatments were found, we will need to discuss the implicaons of 
this very carefully with the team in order to select the best possible combinaon of intervenons to 
take forward to WP5. In this case, the stascal power of the analysis to this point will be inevitably 
reduced.  
For each intervenon, we will tabulate the results based on two models: one with only main effects as 
developed by step 3 and the other including interacon terms as obtained from step 4. The effect 
esmates, standard errors and P-values from these models will be reported. The esmates for 
standard errors and P-values will be used to contrast with the corresponding esmates obtained by 
specifying robust standard errors to assess the likely clustering effect within care homes.  
3.3  Intra-class correlaons. 
To inform sample size calculaon at WP5, a random effect model will be used to analyse the primary 
outcome measure CMAI, to provide appropriate estimates for intra-class correlaons due to care 
homes. Intra-class correlaons for the other outcome measures will be calculated and tabulated in 




Baseline data complete      Complete 
Consort        Complete 
Data extract syntax wrien and tested   Complete 
Baseline demographics described    Complete   
Measure calculaon syntax wrien and tested  August 15th 
DMEC meeng       September 21st 
Follow up entry data complete and handed over  Est. Jan 2013  
Inial results reported      + 4 weeks 
WP5 protocol development     +8 weeks 
Further analysis       April-June 2013 
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APPENDIX 1: EDITED EXTRACTS FROM THE PROTOCOL, OVERVIEW 
A1.1  Glossary of abbreviaons 
AR Antipsychotic Review 
CANE Camberwell Assessment of Need for the Elderly 
CDR Clinical Dementia Rating Scale 
CMAI Cohen-Mansfield Agitation Inventory 
COREC Centre of Research Ethical Campaign 
CONSORT Consolidated Standards of Reporting Trials 
CQC Care Quality Commission 
DEMQOL Measure of Health related quality of life for people with dementia 
DMEC/TSC Data Monitoring and Ethics/Trial Steering Committee 
Ex Exercise 
FAST Functional Assessment Staging 
FITS  
FG  Focus groups 
PCC Person Centred Care 
PI Principle Investigator 
ICCs Intra class correlations 
NEST  
NICE National Institute for Clinical Excellence 
NIHR National Institute of Health Research 
NPI-NH Neuropsychiatric Inventory – Nursing Home version 
NWORTH North Wales Organisation for Randomised Trials in Health 
QoL Quality of Life 
QoL-AD Quality of Life in Alzheimer’s Disease 
RAID Rating Anxiety in Dementia 
RCT Randomised Controlled Trial 
SDs Standard Deviations 
SI Social Interaction 
TMG Trial Management Group 
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WHELD An optimized intervention “welding together” the most effective elements of the best 
currently available intervention programmes and a standardised manual and training 
programme 
WP Work Package 
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A1.2 Trial administraon
A1.2.1 Trial Management Group (TMG) 
Chief Invesgator (Clinical): Prof Clive Ballard
Co-invesgators: Ms Jane Fossey 
Prof Marn Orrell Prof Dag Aarsland 
Prof Esme Moniz-Cook  Ms Joanna Murray 
Prof Robert Woods Prof Marn Knapp 
Mr Eddie McLaughlin Dr Susanne Sorensen 
Mrs Rhiannon Whitaker Mrs Barbara Woodward-Carlton
Trial Manager/Coordinator: Dr Jane Stafford
Trial Stascian and NWORTH Clinical Trials Unit (CTU) Invesgator (Methodological): Rhiannon
Whitaker
A1.2.2 Data Management Centre





700,000 people in the UK have demena, 250,000 of whom live in care homes.  These individuals have
complex mental health problems, disabilies and social needs, compounded by widespread
prescripon of harmful sedave drugs. Demena is a naonal priority with a vast impact on Health and 
Social Care Services. The opmized programme (WHELD) will combine the most effecve elements of
exisng approaches to develop a comprehensive but praccal intervenon. This will be achieved by
training care staff to provide care that is focused on an understanding of the individual and their needs;
and by using addional components such as exercise, acvies and social interacon to improve mental
health, reduce the use of sedave drugs and also improve quality of life (QoL).
Work Package 3 (WP3) is the pilot study and qualitave evaluaon to help develop the larger
randomised controlled clinical trial (Work Package 5, WP5) which will establish the value of WHELD.
The overarching goal of the programme is to provide an effecve, simple and praccal intervenon,
which improves mental health of, and reduces sedave drug use in, people with demena in care
homes; which can be rolled out nationally to all UK care homes as an NHS intervenon.
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Demena      Care Homes    Quality of life 
Anpsychoc medicaon Behavioural symptoms  Cost effecveness 
Implementaon   Person centred care  Exercise 
Social interacon 
A1.4  Keywords 
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A1.5  Study Summary 
 
TITLE Work Package 3 WHELD programme 
DESIGN Pilot factorial trial and qualitave and process evaluaon ulising focus groups.  




 Agitaon, other behavioural and neuropsychiatric symptoms 
 Anpsychoc and other psychotropic drugs use 
 Mood and depression, quality of life, demena severity 
 Unmet needs 
 Falls 
 Quality of interacons between staff and residents using the observaonal tool 
 Amount of staff me needed and cost of each intervenon 
Qualitave: 
 Use of case examples to understand the skills development and development of 
person centred atudes amongst care home staff 
 The process of implementaon within the environment in which the intervenons 
take place.  Staff beliefs, atudes and behaviour in their work with people with demena  
are key components of this context.  Staff perspecves on the implementaon of the 
intervenons. 
POPULATION Residents of 16 care homes  
ELIGIBILITY Care homes idenfied from those rated ‘adequate’ or beer in the CQC register, in the 
Oxfordshire, Buckinghamshire and London localies. 
8 homes selected from a convenience sample and another 8 randomly selected. 
Exclusion criteria: 
 Less than 60% of the residents have demena. 
 Receiving special support from local authority 
 
All individuals residing in parcipang care homes who scores ‘1’ or greater on the CDR and 
score ‘4’ or greater on the FAST. 
Exclusion criteria: 
 Data will not be collected from individuals for whom consent has not been obtained 
DURATION Up to 20 months 
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APPENDIX 2:  EDITED EXTRACTS FROM THE PROTOCOL:WP3  
A2.1   Study Objecves 
Quantave Evaluaon will be undertaken using a factorial design.  Evaluaons will be undertaken to 
understand the breadth of addional benefits conferred by 3 key intervenons compared with Person 
Centred Care alone. 
(A) Person Centred Care        (PCC) 
(B) Anpsychoc Review (disconnuation and safety)  (AS) 
(C) Social intervenon and Pleasant Acvies    (SI) 
(D) Exercise        (EX) 
 
A2.1.1  Hypotheses 
We hypothesise that each intervenon will significantly improve several key outcomes, but none of the 
intervenons will improve all outcomes on their own.  This pilot study is not powered to answer these 
quesons definively.  The role of these hypotheses is to guide the analysis and to generate firm 
hypotheses for tesng in the main trial (WP5). 
Specifically we hypothesise that, compared to Person Centred Care alone: 
(1) The combinaon of Person Centred Care and Anpsychoc Review will result in the reducon of 
anpsychoc prescribing 
 
(2) The combinaon of Person Centred Care and Social intervenon and Pleasant Acvies will result 
in addional improvements in agitaon/aggression, especially in individuals already experiencing 
these symptoms at the baseline evaluaon 
 
(3) The combinaon of Person Centred Care and Exercise will improve overall mood and will reduce 
the number of falls 
 
A2.1.2  Secondary objecves and qualitave evaluation 
A key secondary objecve will be to determine the specific impact of each therapy on a range of 
outcomes including mental health, psychotropic drug use, physical health and quality of life; as well as 
the impact on potenally important mediang factors such as acvies, social interacon, staff 
atudes and the quality of the interacon of care staff with people with demena to inform 
subsequent work. 
The purpose of the qualitave research is to increase our understanding of the process of 
implementaon within the care environment.  Staff beliefs, atudes and behaviour in their work with 
people with demena are key components.  Recognion and acknowledgement of staff perspecves is 
also essenal to negoang the implementation of the intervenons. 
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A 2.2  Study design 
 
A2.2.1  Overall design 
The study design is a cluster randomised, 2x2x2 factorial design with 2 replicaons, pilot study in 16 
care homes.  It is esmated that each cluster will include a minimum of 12 parcipants (depending upon 
size of the care home, the number of people with demena and the number consenng). 
Each cluster will receive a randomly allocated intervenon for a minimum of 9 months. 
Evaluaons will be undertaken to understand the breadth of benefits conferred by 3 key intervenons 
to be assessed when used in addion to the Person Centred Care training package, whose efficacy ha s 
already been established. 
(A) Person Centred Care (PCC):  PCC training will be delivered using the operaonalized FITS manual [2], 
with demonstrated efficacy in a robust randomised controlled trial (RCT) [3] and incorporang relevant 
updated materials since original publicaon.  This will be further augmented by addional elements of 
leadership training on the basis of input from an expert therapy development group. 
 
(B) Anpsychoc Review:  This will involve specific review of anpsychoc drugs by parcipants’ own 
General Praconers or specialists, based upon the principles outlined in the NICE demena guidelines 
[1] and facilitated by an anpsychoc care pathway developed by the Alzheimer’s Society in partnership 
with the Department of Health.  General Praconers will be offered an inial seminar outlining the 
best pracce guidelines and they will be prompted when 12 week anpsychoc reviews are due (as 
advised by the NICE/SCIE guidelines).  Care home staff will also be offered a seminar about the safe 
prescribing, monitoring and review of anpsychocs.  In addion, for all parcipants connuing to 
receive anpsychocs aer the inial review or where anpsychocs are started or re-started, a 
detailed medical anpsychoc care plan will be advised, using the principles outlined in the 
anpsychoc care pathway.  This will include planned dates for further anpsychoc review. 
 
(C) Social Interacon and Pleasant Acvies:  An intervenon manual will be developed based upon 3 
evidence based approaches and specific communicaon skills training to enhance staff–resident 
interacons.  The approaches will include: (1) The Posive Events Schedule, developed and 
demonstrated to be effecve in the treatment of agitaon and depression in people with demena in 
non-care home sengs [44]; (2) The Social Interacon intervenon demonstrated to be effecve for 
the treatment of agitaon in people with demena in care homes by Cohen-Mansfield and colleagues 
[6]; (3) The NEST programme developed by Beuner and colleagues [7].  Minor adaptaons will be 
undertaken, in collaboraon with the authors who developed the manuals, to ensure that they are 
suitable and praccal for administraon in a UK care home seng. 
 
(D) Exercise:  The main focus will be to promote exercise through encouraging enjoyable posive 
acvies that involve exercise.  Teri and colleagues have developed an effecve approach, based upon 
their Posive Event Schedule approach, but focussing specifically on exercise based acvies [5].  The 
NEST manual [7]  and the ROM Dance programme [8], which has been shown to be effecve in an RCT 
for older people in care sengs with Arthris [9], will be used as specific resources to offer people 
enjoyable individual and group exercise acvies to augment acvies idenfied specifically as hobbies 
or enjoyable acvies by individual parcipants. 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
A + + + + + + + + + + + + + + + + 
B - - - -  + + + + - - - -  + + + + 
C - - + + - - + + - - + + - - + + 
D - + - + - + - + - + - + - + - + 
 
In the above design, care homes 1 and 9 will receive PCC only, while care home 4 will receive Social 
Interacon and Exercise in addion to PCC and care home 13 will just receive Anpsychoc Review in 
addion to PCC. 
Each intervenon will be delivered by 2 trained therapists, who will receive an intensive 10 day training 
package, each of whom will coordinate the delivery of the intervenon into 8 care homes. Part of the 
intervenon will be to train 2 lead care staff members (WHELD champions) in each care home to 
implement the intervenon. 
A 2.2.2 Number of participants and power of the study 
16 suitable care homes will be idenfied, recruited, randomised and the intervenon delivered to all 
parcipang residents.  The minimum target parcipant recruitment is 12 individuals with demena 
per care home, therefore the target minimum sample size is 192, with a suggested upper recruitment 
limits of approximately 256 (i.e. 16 individuals with demena per care home). 
Baseline and follow up data will be collected on all consented residents who meet the inclusion criteria 
at each parcipang care home.  This is a pilot study, whose main purpose is to collect data to enable 
the design and sample size calculaon for the follow on RCT.  As such the size of effect for the outcome 
measures, their standard deviaons (SDs) and intra class correlaons (ICCs) are unknown. 
A2.2.3 Randomisation 
A restricted randomisaon method will allocate the 8 intervenons to the 8 care homes in the two 
samples.  The randomisaon will be completed as a complete list randomisaon meaning that all care 
homes will have been recruited before the randomisaon is performed.  The restricon ensures an 
equal distribuon of the number of intervenons to each geographic locaon.  The system has been 
coded and validated in R (stascal package). 
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A2.2.4  Design and Consort diagram 
  
 Number of individual participants 
Care 
Homes 
In home Eligible Consented Completed 
Intervenon 
Followed up 
1&9      
2&10      
3&11      
4&12      
5&13      
6&14      
7&15      
8&16      
 
Convenience     List       Intervenon 
Sample      Sample  Allocaon 
Block 1   Block 2 
    1             9          PCC 
    2             10       PCC   Ex 
    3             11       PCC  SI   
    4              12       PCC  SI Ex 
    5             13       PCC AR  
    6             14       PCC AR  Ex 
    7             15      PCC AR SI  
    8             16       PCC AR SI Ex 





Reasons for non participaon 





Reasons for non participaon 
Randomise 
Intervenon 
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A.2.2.5 Flow Chart (full milestones shown in WHELD Programme Gan chart)
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A2.3 Participant Entry 
 
A 2.3.1 Home selection: inclusion, exclusion and withdrawal criteria 
8 care homes will represent a convenience sample (block 1) of local care homes, already known to the 
research team, which meet the inclusion and exclusion criteria and have previously expressed a 
willingness to parcipate in research.  The other 8 care homes will be idenfied from all care homes in 
the research area rated as ‘adequate’ or beer on the CQC register (block 2).  The list of eligible care 
homes will be randomised and the homes approached in the order of appearance on the randomised 
list.  If a care home declines to parcipate the next care home on the list will be approached. 
 
Inclusion: 
 Care homes scoring ‘adequate’ or beer on CQC register 
 
Exclusion: 
 Care home in which 60% or less of the residents have demena  
 Care homes receiving special support from local authority 
 
Withdrawal Criteria: 
 Care homes are free to withdraw from the study at any me. 
 
A2.3.2 Participant selection: inclusion, exclusion and withdrawal criteria 
All residents who would be potenally eligible for evaluaon will be idenfied by the care home staff. 
 
Inclusion for evaluaon: 
 All individuals residing in parcipang care homes who meet diagnosc criteria for demena, 
score ‘1’ or greater on the CDR [11] and score ‘4’ or greater on the FAST [10]. 
 
Exclusion from evaluaon: 
 Any resident for whom consent is not obtained 
 
Withdrawal Criteria: 
 Individual parcipants would be able to withdraw from the study evaluaon at any me. 
 
A 2.3.3 Staff selection: inclusion, exclusion and withdrawal criteria 
All staff working in parcipang care homes would be potenally eligible to parcipate in the focus 
groups as part of the qualitave evaluaon.  Consent for their parcipaon will be sought separately.  
They will be excluded if consent is not obtained and are able to withdraw from the study at any me. 
DOI: 10.3310/pgfar08060 Programme Grants for Applied Research 2020 Vol. 8 No. 6
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Ballard et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
91
APPENDIX 3:  REFERENCES 
 
1. Naonal Instute for Health and Clinical Excellence/ Social Care Instute for Excellence (2007) 
Demena: the NICE SCIE guideline on supporting people with demena and their carers in 
health and social care, Naonal Collaborang Centre for Mental Health. 
 
2. Fossey, J. & James, I. (2008) Evidence-based approaches for improving demena care in care 
homes. Alzheimer’s Society: London. 
 
3. Fossey, J., Ballard, C., Juszczak, E., James, I., Alder, N., Jacoby, R. & Howard, R. (2006) Effect of 
enhanced psychosocial care on anpsychoc use in nursing home residents with severe 
demena: cluster randomised trial. BMJ, 332(7544): 756-61. 
 
4. Teri, L., Logsdon, R. G., Uomoto, J. & McCurry, S. M. (1997) Behavioral treatment of depression 
in demena paents: a controlled clinical trial. Journals of Gerontology Series B-Psychological 
Sciences & Social Sciences, 52(4): 159-66. 
 
5. Teri, L., Gibbons, L. E., McCurry, S. M., Logsdon, R. G., Buchner, D. M., Barlow, W. E., Kukull, W. 
A., LaCroix, A. Z., McCormick, W. & Larson, E. B. (2003) Exercise plus behavioral management 
in paents with Alzheimer disease: a randomized controlled trial. JAMA, 290(15): 2015-22. 
 
6. Cohen-Mansfield, J., Libin, A. & Marx, M. S. (2007) Nonpharmacological treatment of agitaon: 
a controlled trial of systemac individualized intervenon. Journals of Gerontology Series 
A-Biological Sciences & Medical Sciences, 62(8): 908-16 
 
7. Buener, L. & Fitzsimmons, S. (2009) N.E.S.T Approach: Demena pracce guidelines for 
disturbing behaviours. Venture Publishing, Inc. 
 
8. Harlowe, D. & Yu, T. (1984) The ROM DANCE Program. Tai Chi Health. 
 
9. Van Deusen, J. & Harlowe, D. (1987) The efficacy of the ROM Dance Program for Adults with 
Rheumatoid Arthris. American Journal of Occupational Therapy, 41(2): 90-95. 
 
10. Riesberg, B. (1988) Funconal Assessment Staging (FAST). Psychopharmacology Bullen, 24: 
653-659. 
 
11. Hughes, C. P ., Berg, L., Danziger, W. L., Coben, L. A. & Marn, R. L. (1982) A new clinical scale 
for the staging of demena. Brish Journal of Psychiatry, 140: 566-572. 
 
12. Cohen-Mansfield, J., Marx, M.S., & Rosenthal, A.S. (1989) A description of agitaon in a 
nursing home. J Gerontol Med Sci, 4: 77-84. 
 
13. Wood, S., Cummings, J. L., Hsu, M-A., Barclay, T., Wheatley, M. V., Yarema, K. T. & Schnelle, J. 
F. (2000) The use of the Neuropsychiatric Inventory in nursing home residents, 
characterizaon and measurement. Am J Geriatr Psychiatry, 8: 75-83. 
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
92
14. Alexopoulos, G. S., Abrams, R. C., Young, R. C. & Shamoian, C.A. (1988) Cornell Scale for 
Depression in Demena. Biol Psychiatry, 23: 271-84. 
 
15. Shankar, K. K., Walker, M., Frost, D. & Orrell, M. W. (1999) The Development of A Reliable and 
Valid scale for rang anxiety in demena (RAID). Aging and Mental Health, 3: 39-49. 
 
16. Reynolds, T., Thornicroft, G., Abas, M., Woods, B., Hoe, J., Leese, M. & Orrell, M. (2000) 
Camberwell assessment of need for the Elderly (CANE): development, Validity and Reliability. 
Brish Journal of Psychiatry, 176: 444-452. 
 
17. Smith, S. C., Lamping, D. L., Banerjee, S., Harwood, R. H., Foley, B., Smith, P., Cook, J. C., 
Murray, J., Prince, M., Levin, E., Mann, A. & Knapp, M. (2007) Development of a new measure 
of health-related quality of life for people with demena: DEMQOL. Psychol. Med., 37: 737-46. 
 
18. Logsdon, R. G., Gibbons, L. E., McCurry, S. M. & Teri, L. (1999) Quality of life in Alzheimer’s Disease: paent and 
caregiver reports. Journal of Mental Health and Aging, 5(1): 21-32. 
 
19. Dean, R., Proudfoot, R., Lindesay, J. (1993) The Quality of Interacon Schedule (QUIS): 
development, reliability and use in the evaluaon of two domus units. Int J Ger Psy, 8: 819- 
826. 
 
20. From Jiska Cohen-Mansfield (1991) Instrucon manual for the Cohen-Mansfield agitaon 
inventory (CMAI). The Research Instute of the Hebrew Home of Greater Washington 
 
21. Woods SW, Chlorpromazine equivalent doses for the newer atypical anpsychocs. J Clin 
Psychiatry 2003; 64: 663-67 (28 in the Australian paper) 
 
22. Cummings J.L. (2009) Neuropsychiatric Inventory - Nursing Home Version (NPI-NH): 
Comprehensive Assessment of Psychopathology in Paents with Demena Residing in Nursing 
Homes. NPITest 
 
23. Cummings JL. The Neuropsychiatric Inventory: Assessing psychopathology in demena 
paents. Neurology 1997; 48 (Supple 6): S10-S16. 
 
24. Alexopoulos, George S. (2002) The Cornell Scale for Depression in Demena: Administraon & 
scoring guidelines. Cornell Instute of Geriatric Psychiatry, Weill Medical College of Cornell 
University. 
DOI: 10.3310/pgfar08060 Programme Grants for Applied Research 2020 Vol. 8 No. 6
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Ballard et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
93
APPENDIX 4: OUTCOME MEASURES  
(CMAI and anpsychoc use are two primary outcome measures) 
Outcome measure Subscale Abbreviation Scoring Thresholds References 
Cohen-Mansfield Agitaon 
Inventory (CMAI) 
  CMAI 
 
Sum of all 29 items (scored 1/2/3/4/5/6/7) 
 






























Sum of all 10 items (scored 1/2/3/4/5/6/7) 
 










Sum of all 5 items (scored 1/2/3/4/5/6/7) 
Anpsychoc use 
 
    Anpsychoc doses were converted into 
chlorpromazine equivalents and then added 
together 
  Woods 2003 [21] 
 
  Proporon of residents 
receiving drugs 
  A binary variable: 1 for on anpsychoc treatment 
and 0 for not on the treatment 
    
Use of other psychotropic 
drugs 
 
    Psychotropic doses were converted into 
chlorpromazine equivalents and then added 
together 
  Woods 2003 [21] 
 
  Proporon of residents 
receiving drugs 
  A binary variable: 1 for on psychotropic treatment 
and 0 for not on the treatment 
































Inventory – nursing home 
version (NPI-NH) 
NPI-NH Neuropsychiatric Inventory has 12 domains in
total. For each behavioural domain, frequency is
rated 1 to 4 and severity is rated 1 to 3. The score 
for each domain is: domain score = frequency × 
severity. A total NPI-NH score can be calculated by 
adding all of the first ten domain scores together. 
All twelve domain total scores can be summed in
special circumstances where the neurovegetave 
symptoms are of parcular importance. 
Occasional Disruptiveness is rated 1 – 5. The 
disrupveness score is not included in the total 
NPI-NH score but should be calculated separately
by summing the disrupveness  scores of the 
behavioural domains.
Woods 2000 [13]; 
Cummings 2009 
[22], 1997 [23] 
Cornell Depression Scale CSDD There are 19 items in total. Each item is rated for 
severity on a scale of 0-2 (0=absent, 1=mild or
intermient, 2=severe). The item scores are 
added.
>10, probable major 
depression







[14], 2002 [24] 
Rang Anxiety in
Demena (RAID) 







Need in the Elderly (CANE)
CANE It is to be noted that scoring is a secondary aspect 
of the CANE as its primary purpose is to idenfy
and assess individual unmet needs. (not used for 
this purpose in this research). The total CANE
score is based on the rating of section 1 of each of


















































































































































































































































































































































  Count total number of 
met needs  
  The variables may take values between 0 and 24 
  






Count total number of 
unmet needs  
  The variable may take values between 0 and 24  
 
  
Count total number of 
needs idenfied  
  The variable may take values between 0 and 24  
 
  
Assessment of QoL for 
people with demena 
(DEMQOL) 
  DemQoL 
 
Sum of 28 items (scored 1/2/3/4). Posive items 
are scored reversely. Higher scores mean a beer 
quality of life. 




  Overall quality of life 
 
  A four-point scale based on the paent's overall 
rang on his/her quality of life (the 29th item in 
the quesonnaire) 
  
Assessment of QoL for 
people with demena 
(DEMQOL proxy) 
Sum of 31 items (scored 1/2/3/4). Posive items 
are scored reversely. Higher scores mean a beer 
quality of life. 
Smith 2007 [17] 
 
 
Overall quality of life DemQol-
proxy 
A four-point scale based on the care giver’s 
overall rang on paent’s quality of life (the 32nd 
item in the questionnaire) 
 
QoL in Alzheimer’s Disease 
(QoL-AD) 
  QoL-AD Sum of 13 items (scored 1/2/3/4). Higher scores 
mean a beer quality of life. 
 Paent and 
caregiver reports can 
be evaluated 
separately and/or 




QoL in Alzheimer’s Disease 
(QoL-AD proxy) 
QoL-AD-proxy Sum of 13 items (scored 1/2/3/4). Higher scores 



















































It can be used as both a qualitave and 
quantative tool to provide a measure of the 
quality of interaction between staff, paents and 
visitors. (used as a quantative tool for WHELD).  
Simple percentages of the quality of interactions 
are perfectly acceptable for straigh
orward 
evidence of the quality of verbal and non verbal 
communication e.g. 20% of observaon were 
posively social (n=20), 70% were basic care 
interacons (n=70), 5% were neutral interaction 
(n=5) and 5% were negave interaction (n=5). The 
scoring rule may depend on how the data were 
collected. 








Incident reporng form 
 
Number of fractures 
within last 12 months 
 
A binary variable: 1 for residents with one or more 
fractures and 0 for none 
  
Proporon of residents 
with one or more falls 
  A binary variable: 1 for residents with one or more 
falls and 0 for none 
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